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Abstract
Background: In recent years, time-restricted feeding, alternate day fasting, and the Daniel Fast
have garnered attention as potential dietary interventions to combat obesity. Objective: To
compare the effects of various dietary models on measures of body composition and physical
performance in male C57BL/6 mice. Methods: 60 young C57BL/6 male mice were assigned a diet
of time-restricted feeding, alternate day fasting, the Daniel Fast, caloric restriction, a high-fat
rodent diet, or a standard rodent chow for 8 weeks. Body composition and run time to exhaustion
were determined. Results: Compared to the high-fat ad libitum group, all groups displayed
significantly less weight and fat mass gain and non-significant changes in fat-free mass.
Additionally, although not statistically significant, all groups displayed greater run time to
exhaustion, relative to the high-fat ad libitum group. Conclusion: The Daniel Fast, time-restricted
feeding, and alternate day fasting may improve body composition and physical performance as
compared to a high-fat diet.
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Introduction
The prevalence of obesity - a complex condition caused by a combination of genetic,
metabolic, social, behavioral, and cultural factors - has risen substantially in the United States since
the year 1976 (1). Recent estimates indicate 36.5% of adult Americans are classified as obese,
defined as a body mass index [BMI] of ≥ 30 kg∙m-2) (2). This figure is important because obesity
is associated with negative alterations to many markers of overall health, notably with unfavorable
changes in body composition (i.e. increased fat mass [FM], abdominal FM, and ratio of FM to fatfree mass [FFM]) (1) and decreased physical fitness (3). Given that the prevalence of obesity is
expected to increase in the coming decades, it is clear that novel interventions are needed to induce
favorable changes in body composition and increases in physical fitness in obese individuals.
In recent years, three dietary modifications have been suggested as potential aids in
preventing and treating obesity: time-restricted feeding (TRF), alternate day fasting (ADF), and
the Daniel fast (DF). TRF regimes restrict daily feeding periods to designated hours of the day (i.e.
only eating from 12:00 pm – 7:00 pm), extending the typical overnight fast by several hours.
Recent studies have indicated that TRF is capable of producing positive alterations in markers of
overall health in humans, including positively altering blood lipids (4, 5), blood glucose (5), and
blood insulin (5). With regard to body composition, studies in both humans (4, 5) and animals (68) have suggested that TRF may be successful in inducing significant reductions in body mass and
FM, while human studies have indicated that FFM can be maintained during this weight loss (4,
5). Few studies have reported measures of physical fitness following a TRF intervention. Studies
in humans have indicated that physical fitness levels are maintained in normal weight individuals
following short-term TRF (5, 9). Two TRF studies conducted using animal models (one using
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C57BL/6J mice and one using Drosophila) have reported greater physical performance in TRF
groups, relative to control groups (10, 11).
Traditional ADF protocols follow the practice of fasting for one day, followed by ad
libitum consumption on the subsequent day. Recent research has also utilized a modified ADF,
which permits the consumption of small meals on fast days, typically consisting of 25-30% of
normal daily caloric consumption (12, 13). Studies suggest that ADF may improve measures of
cardio-metabolic health in humans, including decreased cholesterol (14-16), decreased LDL levels
(14-16), decreased triglyceride levels (14-16), and decreased blood pressure (14, 17, 18).
Additionally, ADF has been shown to improve measures of body composition in humans, resulting
in significant reductions in FM (13-15, 17, 19, 20), visceral FM (20), and waist circumference (17,
18) while maintaining FFM (13, 14, 17). To the author’s knowledge, no studies have reported
measuring physical fitness following ADF.
The DF is a religious motivated fast derived from the Biblical book of Daniel (21).
Typically, individuals partake in the DF for a 21-day period. It is a strict vegan diet that generally
leads to reduced caloric intake. Individuals participating in a DF may consume fruits, vegetables,
whole grains, nuts, legumes, seeds, and healthy oils (such as olive oil) ad libitum. Products that
contain additives or preservatives, as well as caffeine and alcohol, are prohibited. In humans, the
DF has resulted in improvements of many markers of overall health, including blood lipids, blood
pressure, insulin, inflammation, and oxidative stress (21-24). With regards to body composition,
only one study has indicated that DF results in significant alterations in body composition in
humans (23). In this study, body mass, FM, and FFM all decreased significantly. However, other
DF studies have failed to produce significant alterations in body composition, likely the result of
the short duration of the intervention used in the studies (21, 22, 24). However, weight loss is

2

typically 5-6 pounds over the course of a 21-day period. No DF studies have examined physical
fitness in humans. However, one study in Long-Evans rats resulted in a significant increase in
exercise capacity (run time to exhaustion) in mice consuming a DF-inspired chow and participating
in regular exercise, relative to control groups (25). This indicates that the DF may result in
increased physical fitness in rodent models.
Currently, no studies have compared these above dietary interventions within one protocol
with respect to body composition and physical fitness. The proposed study aimed to accomplish
this goal for the first time using a mouse model.
Methods
Mice and Dietary Protocol
Male C57BL/6 mice were used for this study, with 60 mice (7 groups of 8 mice, with 4
additional mice obtained to ensure statistical power was maintained in the event of the death of an
animal) allocated to one of seven groups. Mice were obtained at 4 weeks of age and were cohoused (as described in Hatori, 2012) at the animal facility on the University of Memphis campus.
They were entrained under a 12h light: 12h dark schedule for 2 weeks with standard rodent chow
available ad libitum. During the 2-week entrainment period, mice began the reverse light-dark
schedule, with lights off between the hours of 7am-7pm. This was done so that the feeding time
was during the active phase (“lights off” phase) of the mice. Mice were housed in Life Sciences in
an area that is used for studies of the circadian rhythm, and therefore, the light was well-regulated.
Following the 2-week entrainment period, all mice entered a 6-week lead-in phase. During
this 6-week lead-in period, 8 mice continued consuming a standard chow diet. These mice served
as the control group (referred to as CHOW). They maintained ad libitum consumption of standard
rodent chow through the entire study. The remaining 52 mice consumed a high-fat diet, consisting
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of 45% lard and 41% carbohydrate (20% sucrose, 9% corn starch, and 12% Maltodextrin). This 6week period of ad libitum feeding of a high-fat diet allowed for significant weight gain. Following
the 6-week period lead-in period, the 52 mice fed the high-fat diet were divided into 6 additional
groups (see Tables 1-3 for dietary composition of each diet):
Group 1 (HF) had access to the high-fat diet ad libitum, 24 hours per day (n=8).
Group 2 (SWITCH) had access to a standard rodent chow ad libitum, 24 hours per day (n=8).
Group 3 (DF) had access to a purified, high-fiber, vegan-based diet ad libitum, 24 hours per day
(n=10; 2 additional animals were assigned to this group following the death of 2 animals during
baseline testing). The DF chow consumed by Group 3 (product: D13092801) was custom-made
by Research Diets, Inc., based on the average macronutrient sources and quantities of the dietary
intakes of human participants following the Daniel Fast in our previous studies (25).
Group 4 (CR) received 80% of ad libitum intake as determined during week 6 of the high-fat diet
intake period (n=8).
Group 5 (TRF) had ad libitum access to the high-fat diet for 6 hours at the beginning of their active
phase (8am-2pm) (n=9; an additional animal was assigned to this group a priori because it was
deemed a high-risk group).
Group 6 (ADF) had ad libitum access to the Western diet every other day (n=9; an additional
animal was assigned to this group a priori because it was deemed a high-risk group). That is, on
day 1 they received as much food as desired during the entire 24-hour period. On day 2, they
received no food. On day 3, they received ad libitum access to food, and so on.
The diets were purchased from Research Diets, Inc (New Brunswick, NJ), which has
experience in producing the high-fat diet and purified vegan diets for rodent studies. The mice
remained on their particular diets for 8 weeks and then post-testing began. Mice continued on their
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diets until all testing was completed (~ middle of week 9). Water was provided ad libitum
throughout the study period. The amount of food consumed was measured daily and the weights
of the mice were taken on alternating days. Following the conclusion of post-testing, mice were
euthanized with cervical dislocation (using isoflurane inhalation for anesthesia).
Measurements of Body Composition
Animals underwent a MRI for determination of body mass/body fat. This was done during
the 6th week of the lead-in period (baseline) and 9th intervention week (post-intervention) using a
small animal MRI unit (EchoMRI™) which uses a specialized NMR-MRI-based technology to
rapidly measure lean and fatty tissue in small animals. Baseline and post-intervention scans were
performed on the same days for all animals during the last hour of the animal’s inactive (light)
phase. With regard to the ADF group, baseline and post-intervention scans were performed
following 24 hours of feeding. The total scan time for each animal was approximately 60 seconds.
Animals simply remained in a stationary tubing while the scan was performed. There was no need
to anesthetize the animals during the scan.
Measurements of Physical Fitness
Animals underwent a treadmill run-time-to-exhaustion test using a motorized treadmill
with 5% incline. Animals ran at 20m/min for 30 min and 25m/min for the remaining time until
they reach exhaustion. A warm-up was provided for 15min (5min at 5m/min, 5min at 10m/min,
5min at 15m/min). Exhaustion was defined as the time at which mice were no longer able to
continue running and sat on the shock grid with all 4 paws on the grid for 5 seconds, despite gentle
hand prodding. The very mild electric shock was only used when mice did not respond well to
gentle hand prodding and at the end of the run-time-to-exhaustion test to determine the stopping
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point. The frequency and amplitude of shock was as low as possible (3Hz) to motivate the animals
to remain on the treadmill belt, without causing unnecessary distress.
The run-time-to-exhaustion testing was conducted twice in the mice, once prior to starting
the intervention period (during the 6th week of the lead-in period) and once at the end of the 8th
intervention week. The first run-time-to-exhaustion test was used to acclimate the mice to the
treadmill and the run-time-to-exhaustion protocol. The second test was used as a primary
dependent variable to characterize the aerobic capacity of each group after the 8-week intervention.
Statistical Analysis
Data collected for anthropometric variables and the run-time-to-exhaustion test were
analyzed using GraphPad Prism (GraphPad, LaJolla, CA, USA). A one-way ANOVA was used to
calculate main effects, and Tukey post-hoc tests were used for multiple comparisons. An alpha
value of 0.05 was used for all statistical testing. Cohen’s d was calculated for the run time to
exhaustion data using Microsoft Excel (Microsoft, Redmond, WA, USA) to further explore the
differences observed between the HF group and the DF, TRF, and ADF groups.
Results
Overview
Three animals died during the course of the study. One animal died during the 6th week of
the lead-in period due to sepsis caused by an injury of unknown origin sustained to the left hind
limb. Two animals (1 from the CHOW group and 1 from the DF group) died during the 6th week
of the lead-in period while performing the run-time-to-exhaustion test. Both mice died instantly
from injuries sustained as a result of falling between the shock grid and the treadmill belt. All
remaining animals completed the 16-week study.
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Caloric Consumption Data
Caloric consumption during the 8-week intervention period (Figure 1) displayed multiple
significant group effects. Caloric consumption for HF was significantly greater than for CHOW
(p<0.005), SWITCH (p<0.0001), CR (p<0.005), TRF (p<0.0001), and ADF (p<0.0001). Caloric
consumption for DF was significantly greater than for CHOW (p<0.005), SWITCH (p<0.0001),
CR (p<0.005), TRF (p<0.0001), and ADF (p<0.0001). Caloric consumption for CR was
significantly greater than for ADF (p<0.05). No other effects were noted for caloric
consumption.
Anthropometric Data
All anthropometric data are presented in Table 4. Change in body mass from baseline to
post-intervention (Figure 2) displayed several group effects. Change in body mass for HF was
significantly different from all other groups (p<0.0001). Change in body mass for CHOW
differed significantly from DF (p<0.0001), TRF (p<0.005), and ADF (p<0.0005). Change in
body mass for SWITCH was significantly different from CHOW (p<0.0001), CR (p<0.0001),
TRF (p<0.005), and ADF (p<0.05).
The data for change in FM from baseline to post-intervention are presented in Table 4
and Figure 3. The SWITCH, DF, TRF, and ADF groups displayed decreased FM after the 8week intervention, while the CHOW, HF, and CR groups displayed an increase in FM. As
expected, the HF group gained more FM (6.76±0.46g) than all other groups (p<0.0001). The
greatest decrease in FM was observed in the SWITCH group, which lost significantly more FM
(-6.275±0.86g; p<0.005) than all other groups with the exception of DF (-4.10±0.49g; p>0.05).
Change in FM for CHOW was significantly different from SWITCH (p<0.0001), DF
(p<0.0001), TRF (p<0.005), and ADF (p<0.0005). Change in FM for DF was significantly

7

different from CR (p<0.0005). No significant differences were observed with regard to change in
FM between the DF, TRF (-1.89±0.55g), and ADF (-2.39±0.49g) groups.
Data for the change in FFM from baseline to post-intervention are displayed in Figure 4.
No main effect or group effect was noted. However, the change in FFM between HF - which
gained FFM - and CR - which lost FFM - trended towards significance (p=0.068).
Change in %FM from day 1 of the intervention to the final day of the intervention (Figure
5) displayed several significant group effects. Change in %FM for HF was significantly different
from SWITCH, DF, CR, TRF, and ADF (p<0.0001). Change in %FM for CHOW was
significantly different from SWITCH (p<0.0001), DF (p<0.0001), TRF (p<0.0005), and ADF
(p<0.0001). Change in %FM for SWITCH was significantly different from CR (p<0.0001), TRF
(p<0.0001), and ADF (p<0.0001). Change in %FM for DF was significantly different from CR
(p<0.0001) and TRF (p<0.05). Change in %FM for CR was significantly different from ADF
(p<0.05).
Run Time to Exhaustion Data
Data for the run time to exhaustion are presented in Figure 6. No significant effects were
noted (p>0.05). However, large effect sizes were observed when comparing DF to HF (d=1.10),
TRF to HF (d=0.99), and ADF to HF (d=1.10).
Discussion
To our knowledge, this is the first study to compare the effects of dietary protocols
mimicking caloric restriction, the Daniel Fast, time-restricted feeding, and alternate day fasting
on measures of body composition and physical performance in male C57BL/6 mice. Our results
indicate that the CR, DF, ADF, and TRF protocols used in this study produce favorable
alterations in body composition in male C57BL/6 mice. Additionally, though the differences
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between groups were not significant, the DF, TRF, and ADF groups displayed greater run time to
exhaustion when compared with the HF group, with large effect sizes noted.
Anthropometric Findings
As can be seen in Table 4 and Figure 2, the SWITCH, DF, CR, TRF, and ADF groups all
displayed decreased body mass after the 8-week intervention. SWITCH displayed the greatest
decrease in body mass, losing significantly more weight than all groups besides DF. No
significant differences were observed with regard to change in body mass between the DF, CR,
TRF, and ADF groups, indicating that all of these diet regimes are effective for inducing weight
loss and/or preventing excessive weight gain following a period of high-fat feeding. As expected,
the CHOW and HF groups exhibited increased body mass after the 8-week intervention. The
increase in body mass displayed by the CHOW group is characteristic of the normal growth of
C57BL/6 mice, and the increase in body mass displayed by the HF group is characteristic of the
growth rate of C57BL/6 mice given ad libitum access to a calorically dense diet.
With regard to body composition, the SWITCH, DF, TRF, and ADF groups displayed
decreased FM (Table 4 and Figure 3) after the 8-week intervention, while the CHOW, HF, and
CR groups displayed an increase in FM. As noted above, the greatest decrease in FM was
observed in the SWITCH group, which lost significantly more FM than all other groups with the
exception of DF. No significant differences were observed with regard to change in FM between
the DF, TRF, and ADF groups; although, it should be noted that the DF group displayed the
lowest post-intervention FM despite consuming the most kilocalories during the 8-week
intervention period (Table 4). These data indicate that the DF, TRF, and ADF protocols used in
this study can effectively decrease FM following a period of high-fat feeding, albeit likely
through different mechanisms. TRF and ADF likely reduced FM by inducing a form of caloric
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restriction while DF likely modulated FM via the quality of the macro-and-micronutrients
contained in the purified vegan rodent chow.
Figure 4 presents data respective to change in FFM after the 8-week intervention. No
main or group effects were noted for this data, though the comparison between HF and CR
trended towards significance (p=0.068). This lack of a significant main effect is likely due to the
relatively small changes in FFM observed after the 8-week intervention, coupled with the small
group sizes and the relatively large variation observed (SEM). However, it is worth noting that
only the CR and ADF groups displayed decreased FFM after the 8-week intervention. Animals
in the DF and TRF groups actually gained FFM over the course of the 8-week intervention. The
gain in FFM observed in the DF group is particularly notable because the purified vegan rodent
chow consumed by the DF group contains only soy protein; it does not contain any animal
protein. These data demonstrate that the TRF and DF protocols used in this study can maintain
FFM, even during periods of weight and fat loss.
Many of the findings discussed in this section are consistent with the anthropometric
measures reported by other animal studies that utilized DF, TRF, and ADF dietary protocols.
Studies have consistently reported significant reductions in body mass following the DF (25),
TRF (6, 8, 26, 27), and ADF (28-30) protocols in animal models. With regard to body
composition, the DF (25) and TRF (8, 26) protocols have often resulted in reductions in FM,
while only one animal study (31) has indicated that ADF results in decreased FM, relative to
control. However, it should be noted that many of these studies, and all of the ADF studies
mentioned here, use epididymal FM as a measure of overall FM. The current study measured FM
using a small animal MRI.
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The available FFM data relevant to the DF compares well to the data reported in the
current study. Notably, our previous work with the DF in male Long-Evans rats reported
maintenance of FFM following 12 weeks of purified vegan rodent chow consumption, despite
weight loss and decreased FM (25). Measures of FFM have not been reported following TRF or
ADF protocols in animals. It should be noted, though, that a number of human studies have
reported reductions in body weight and FM while maintaining FFM following TRF (4, 5) and
ADF (13, 14, 17) protocols.
Taken together, the data from the current study and other studies mentioned here indicate
that DF, TRF, and ADF protocols are capable of producing favorable alterations in body
composition. The DF appears to produce the best results with regard to anthropometric measures
of body composition in animal models, though more studies are needed to confirm these
findings. Additionally, TRF and ADF protocols appear to be viable options for individuals
seeking to decrease body mass and FM while consuming a Western diet that is high in fat and
simple sugar. More work is needed to compare the effects of the DF, TRF, and ADF on
measurements of body composition.
Run Time to Exhaustion Findings
As indicated by Figure 6, no main or group effects were observed for the run-time-toexhaustion test. The lack of a significant main effect in these data is likely due to the small group
sizes and the relatively large standard error observed. Additionally, the animals’ genetic aerobic
capacity likely affected run time to exhaustion. For example, during our run-time-to-exhaustion
tests, many of the animals had difficulty running at the predetermined testing speed, even during
the early stages of testing (20m/min). It may be that some of these animals simply possessed
genetic qualities that predisposed them to poor physical performance.
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Despite the lack of a significant main effect, however, it is valuable to highlight the mean
values for the main intervention groups. The mean run time for the DF (39.00±2.90min), TRF
(40.00±4.88min), and ADF (27.78±3.30min) groups was greater than the mean run time for the
HF group (16.38±3.85min). Additionally, large effect sizes were observed when the mean run
time for the DF (d=1.10), TRF (d=0.99), and ADF (d=1.10) groups were compared with the HF
group. These data indicate that the DF, TRF, and ADF protocols had a large impact on run time
to exhaustion performance, when compared with the HF group. This may be attributed to the
relatively higher FM of the HF group. Further, because the mean run time for the DF and TRF
groups closely resembled the mean run time for the CHOW group (39.86±7.87min), the DF and
TRF dietary appear to optimize performance, relative to ADF.
As mentioned above, literature describing the effects of DF, TRF, and ADF on physical
performance is scant. Only one known study has reported any measure of physical performance
following a DF intervention in animals (25). Conducted in male Long-Evans rats, this study
indicated the DF combined with regular exercise results in significantly greater aerobic
performance than a high-fat diet combined with regular exercise. However, run time between the
DF and high-fat groups that did not participate in regular exercise did not differ significantly,
findings that align well with the findings of the current study. With regard to TRF studies in
animals, one study (11) has reported that C57BL/6J mice following TRF protocols display
significantly greater run time to exhaustion, relative to a high-fat control, and another study has
indicated that TRF improves physical performance (as measured by flight index) in Drosophila
(10). Additionally, studies have indicated that TRF does not diminish physical performance in
humans, relative to a control (5, 9). No animal model or human subject studies have reported any
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measurement of physical fitness following an ADF intervention. More work is needed to
investigate the impacts of DF, TRF, and ADF on measures of physical performance.
Conclusions
To our knowledge, this is the first study to compare the effects of dietary protocols
mimicking caloric restriction, the Daniel Fast, time-restricted feeding, and alternate day fasting
on measures of body composition and physical performance in male C57BL/6 mice. The
findings presented here indicate that the Daniel Fast, time-restricted feeding, and alternate day
fasting are viable option for improving anthropometric measures and physical performance,
when compared with an ad libitum high-fat diet.
Future Directions
Future research using animal models and human participants are needed to more fully
elucidate the mechanisms responsible for the improved anthropometric measures in response to
the Daniel Fast, time-restricted feeding, and alternate day fasting. Specifically, research should
focus on the caloric consumption of each group and relate it to changes in anthropometrics. For
example, in the present study, the Daniel Fast group consumed the greatest number of
kilocalories during the intervention period, yet the Daniel Fast group also had the lowest FM.
Future research should determine the causes of the noted changes and seek to address these
results more specifically.
Additionally, future studies should aim to better characterize the effects of the Daniel
Fast, time-restricted feeding, and alternate day fasting on physical performance, both in an
animal model and with human participants. These studies should use larger sample sizes than
what was used in the present study to better mitigate the effects of within group variation in
physical performance. Future studies should utilize baseline and post-intervention performance
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tests to measure changes in physical performance after the completion of the dietary
interventions. Additionally, future studies aiming to characterize physical performance following
DF, TRF, and ADF should likely aim to control body mass between groups to better measure the
effects of the dietary protocols on physical performance, independent of body mass.
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Figure 1. Total kilocalories consumed during the 8-week intervention period by male mice
assigned to seven different dietary protocols.
Values are Mean ± SEM
* A group effect noted for caloric consumption: HF>CHOW, SWITCH, CR, TRF, & ADF
(p<0.005)
† A group effect noted for caloric consumption: DF>CHOW, SWITCH, CR, TRF, & ADF
(p<0.0005)
‡ A group effect noted for caloric consumption: CR>ADF (p<0.05)
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Figure 2. Change in total body mass (g) from baseline (start of the intervention) to the last day of
the 8-week intervention of male mice assigned to seven different dietary protocols.
Values are Mean±SEM
§ A group effect noted for change in body mass: CHOW different from SWITCH, DF, TRF, &

ADF (p<0.005)
* A group effect noted for change in body mass: HF different from all groups (p<0.0001)
¥ A group effect noted for change in body mass: SWITCH different from CR, TRF, & ADF
(p<0.05)
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Figure 3. Change in FM (g) from baseline (start of intervention) to the last day of the 8-week
intervention of male mice assigned to seven different dietary protocols.
Values are Mean±SEM
§ A group effect noted for change in FM: CHOW different from SWITCH, DF, TRF, & ADF

(p<0.005)
* A group effect noted for change in FM: HF different from all groups (p<0.0001)
¥ A group effect noted for change in FM: SWITCH different from CR, TRF, & ADF (p<0.0005)
† A group effect noted for change in FM: DF different from CR (p<0.0005)
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Figure 4. Change in FFM (g) from baseline (start of intervention) to the last day of the 8-week
intervention of male mice assigned to seven different dietary protocols.
Values are Mean±SEM
No main or group effects observed (p>0.05)
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Figure 5. Change in percent fat mass (%FM) from baseline (start of intervention) to the last day
of the 8-week intervention of male mice assigned to seven different dietary protocols.
Values are Mean±SEM
§ A group effect noted for change in %FM: CHOW different from SWITCH, DF, TRF, & ADF
(p<0.0005)
* A group effect noted for change in %FM: HF different from SWITCH, DF, CR, TRF, & ADF
(p<0.0001)
¥ A group effect noted for change in %FM: SWITCH different from CR, TRF, & ADF
(p<0.0001)
† A group effect noted for change in %FM: DF different from CR & TRF (p<0.05)
# A group effect noted for change in %FM: CR different from ADF (p<0.05)
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Figure 6. Run time to exhaustion (min) in male mice assigned to seven different dietary protocols
for 8 weeks.
Values are Mean±SEM
While no main or group effects were observed (p>0.05), all groups demonstrated a higher mean
run time to exhaustion, relative to HF.
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Table 1. Macronutrient composition and Caloric Density of Experimental Diets.
Macronutrient
Protein
Carbohydrate
Fat
kcal/gm

DF
kcal%
15
59
25
3.9

HF
CHOW
kcal% kcal%
24
20
58
35
18
45
4.73

3.1

Table 2. Ingredient List of Daniel Fast and High-Fat Diets
DF
Casein
Soy Protein
DL-Methionine
Corn Starch
Corn Starch-Hi Maize
260
(70% Amylose and 30%
Amylopectin)
Maltodextrin
Sucrose
L-Cystine
Cellulose, BW200
Inulin
Soybean Oil
Lard
Flaxseed Oil
Safflower Oil, High Oleic
Ethoxyquin
DiCalcium Phosphate
Mineral Mix S10001
Calcium Carbonate
Mineral Mix S10026
Vitamin Mix V10001
Choline Bitartrate
Ascorbic Acid Phosphate,
33% active
Potassium Citrate, 1 H2O
Cholesterol
FD&C Red Dye #40

HF

gm
0
170
3
0

kcal
0
680
12
0

gm
200
0
0
72.8

kcal
800
0
0
291

533.5

2134

0

0

150
0
0
100
50

600
0
0
0
50

0
71
59
0.04

0
639
531
0

35
4

0
0

10
2

40
0

100
172.8
3
50
0
25
177.5
0
0
0
13
10
5.5
10
0
2

400
691
12
0
0
225
1598
0
0
0
0
40
0
0
0
0

0.41

0

0

0

0
0
0.05

0
0
0

16.5
0
0.05

0
0
0
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Table 3. Macronutrient and Micronutrient Composition of Standard Rodent Chow
Micronutrients

Amino Acids

Calcium

%

1 Aspartic Acid

%

1.4

Phosphorous

%

0.7 Glutamic Acid

%

3.4

Non-Phytate Phosphorous

%

0.4 Alanine

%

1.1

Sodium

%

0.2 Glycine

%

0.8

Potassium

%

0.6 Threonine

%

0.7

Chloride

%

0.4 Proline

%

1.6

Magnesium

%

0.3 Serine

%

1.1

Zinc

mg/kg

70 Leucine

%

1.8

Manganese

mg/kg

100 Isoleucine

%

0.8

Copper

mg/kg

%

0.9

Iodine

mg/kg

%

1

Iron

mg/kg

200 Tyrosine

%

0.6

Selenium

mg/kg

0.23 Methionine

%

0.4

%

0.3

15 Valine
6 Phenylalanine

Cysteine

Vitamins
Vitamin A e,f

IU/g

15 Lysine

%

0.9

IU/g

1.5 Histidine

%

0.4

Vitamin E

IU/kg

110 Arginine

%

1

Vitamin K3 (menadione)

mg/kg

50 Tryptophan

%

0.2

Vitamin B1 (thiamin)

mg/kg

17 Fatty Acids

Vitamin B2 (riboflavin)

mg/kg

15 C16:0 Palmitic

%

0.7

Niacin (nicotinic acid)

mg/kg

70 C18:0 Stearic

%

0.2

Vitamin B6 (pyridoxine)

mg/kg

18 C18:1ω9 Oleic

%

1.2

Pantothenic Acid

mg/kg

33 C18:2ω6 Linoleic

%

3.1

Vitamin B12
(cyanocobalamin)
Biotin

mg/kg

0.08 C18:3ω3 Linolenic

%

0.3

%

0.9

Folate

mg/kg

%

1.3

Choline

mg/kg

%

3.4

Vitamin D3

e,g

mg/kg

0.4 Total Saturated
4 Total Monounsaturated
1200 Total Polyunsaturated
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Table 4. Anthropometric and run time to exhaustion data for male mice assigned to seven
different dietary protocols for 8 weeks.

Body Mass

FM

FFM

(g)

(g)

(g)

%FM

Run time to
exhaustion
(min)

PRE

POST

PRE

POST

PRE

POST

PRE

POST

POST

CHOW

25.49±0.66

27.79±1.03

2.48±0.38

4.21±0.71

21.05±0.48

21.30±0.39

0.10±.0.1

0.15±0.02

39.86±7.87

HF

30.54±1.01

39.60±1.71

7.96±0.72

14.72±0.92

20.64±0.37

22.03±0.85

0.26±0.02

0.37±0.01

16.38±3.85

SWITCH

33.90±0.79

28.65±0.83

10.71±0.68

4.43±0.89

21.20±0.34

22.02±0.34

0.31±0.01

0.15±0.03

42.13±9.01

DF

31.83±1.02

28.91±0.5

7.82±0.84

3.72±0.44

21.97±0.57

22.85±0.76

0.24±0.02

0.13±0.01

39.00±9.4

CR

34.12±1.05

33.69±1.01

10.55±0.82

10.56±0.62

21.50±0.30

20.78±0.86

0.31±0.02

0.31±0.01

30.63±5.38

TRF

30.03±1.06

28.47±0.63

7.80±0.89

5.91±0.51

20.31±0.31

20.50±0.26

0.25±0.02

0.21±0.01

40.00±10.68

ADF

30.96±0.56

28.64±0.40

7.75±0.63

5.36±0.35

21.13±0.23

20.91±0.38

0.25±0.02

0.19±0.01

27.78±3.30

Values are Mean±SEM
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Appendix B
Literature Review
Introduction
The prevalence of obesity - a complex condition caused by a combination of genetic,
metabolic, social, behavioral, and cultural factors - has risen substantially in the United States since
the year 1976 (1). As of 2014, the WHO estimated that, worldwide, 35% of adults over the age of
20 years were overweight (body mass index [BMI] ≥ 25 kg∙m-2), with 10% of men and 14% of
women being classified as obese (BMI ≥ 30 kg∙m-2) (2). The United States exhibits particularly
high levels of overweight and obesity. More than one in three (36.5%) adult Americans is classified
as obese (3). More than two in three (69.2%) adult Americans are classified as either overweight
or obese. In Americans, obesity is more prevalent in non-Hispanic blacks (48.1%) and Hispanics
(42.5%) when compared to both the national average and non-Hispanic whites (34.5%), and nonHispanic Asians (11.7%). Additionally, obesity is more prevalent in older adults than in younger
adults: the prevalence of obesity in Americans ages 40-59 (40.2%) and Americans age 60 and
older (37.0%) is generally greater than the prevalence of obesity individuals age 20-39 (32.3%).
Perhaps more troubling, these trends extend to the youth of America. The Centers for Disease
Control and Prevention (CDC) estimate that 12.7 million (17%) American adolescents age 2-19
suffer from obesity (defined as BMI in kg∙m-2 greater than or equal to the age- and sex-specific
95th percentile of the 2000 CDC growth charts).
Obesity places a major financial burden on the healthcare system of the U.S. In 2011, Tsai
et al. estimated that overweight status and obesity accounted for $170.2 billion U.S. dollars (7.1%)
of the total healthcare dollars spent (4). The authors noted that this obesity-related spending
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doubled or tripled the percentage of healthcare dollars spent to combat obesity in several other
developed nations, including Canada and nations in the European Union (4). Unfortunately, the
future looks even bleaker. Experts have projected direct healthcare costs for preventing,
diagnosing, and treating overweight and obesity will rise to 16-18% of total healthcare dollars
spent in the U.S. by the year 2030.
In addition to causing a great national financial burden, obesity may substantially reduce
an individual’s quality of life, impacting physical, psychological, and financial functioning (5).
Obese individuals often experience some degree of decreased physical and psychological function.
Notably, aerobic and anaerobic capacity, ability to perform basic tasks, ability to perform at work,
and ability to sleep (including the development of sleep apnea) may decline with obesity (6-10).
These decreases in physical function may be accompanied by, or compounded by, some
combination of feelings of depression, shame, guilt, and social isolation, as well as other potential
psychological stressors (5, 11-13). Moreover, because obesity has been linked to cardiovascular
disease (CVD) (14, 15), type II diabetes (16), and some forms of cancer (including colon, kidney,
endometrial, and postmenopausal breast cancers) (17, 18), individuals may have no choice but to
spend a substantial amount of money to assuage the negative healthcare outcomes associated with
obesity. Studies have estimated that obese individuals spend as much as $1429-$1723 more per
year on healthcare when compared to individuals of normal weight (BMI between 18 and 25 kg∙m2

) (4, 19).

Weight Loss Strategies
The figures and statistics listed above make it clear that obesity is a major healthcare
problem, and an intervention is needed. Several strategies exist that may help an individual lose
weight. They exist on three tiers. The first tier of weight loss strategies, dietary intake and physical
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activity/exercise, may be implemented by an individual at home. Dietary modification can
effectively stimulate weight loss in obese individuals (discussed in further detail below). Exercise,
of sufficient volume and intensity, has also been shown to decrease fat mass and, thus, BMI (20).
The second tier of weight loss strategies requires intervention by healthcare professionals.
These methods should be employed after the first tier of intervention has been deemed
unsuccessful with regards to obtaining the needed weight loss/health outcomes. These strategies
include weight-loss counselling by a registered dietitian or a counselor, as well as consideration
for the use of prescription weight-loss drugs. The Food and Drug Administration (FDA) has
approved several drugs designed to induce weight loss, including lorcaserin and phentermine–
topiramate, which have been shown to assist individuals with weight loss goals (21).
The third and final tier consists of bariatric surgeries. These surgeries, such the
Laparoscopic Adjustable Gastric Banding (LAGB), Laparoscopic Sleeve Gastrectomy (LSG), and
Roux-en-Y Gastric Bypass (RYGB), are typically reserved for individuals with extremely high
BMIs (BMI > 40 kg∙m-2). These surgeries should be considered as a last resort for those seeking
weight loss and should be reserved for those who have medical conditions secondary to being
obese. However, they have been shown to be extremely effective in individuals who have extreme
trouble with losing weight.
The intervention that is most applicable to the average obese person include lifestyle
modification, involving increased physical activity and diet modification. Perhaps the most
recognizable form of diet modification is caloric restriction. Caloric restriction (CR) consists of
restricting the number of calories consumed per day. Typically, CR attempts to reduce caloric
intake by 20-40% of ad libitum consumption, achieved by consuming a reduced volume of food
at feeding periods (22). CR has been shown to increase lifespan and improve myriad health
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markers (22-24). Because of the low tolerability of CR in human populations (25), researchers and
healthcare professionals have developed indirect methods to achieve caloric restriction that are
better tolerated by humans. One such method is intermittent fasting (IF). IF is a general term that
describes any dietary modification in which an individual intentionally alternates between periods
of “feeding” and extended, self-induced “fasting” (26). Two notable methods of IF have emerged:
time-restricted feeding (TRF) and alternate day fasting (ADF). TRF restricts daily feeding periods
to designated hours of the day (i.e. only eating from 12:00 pm – 7:00 pm), extending the typical
overnight fast by several hours. TRF often, but not always, reduces daily caloric intake by
reducing feeding time. Alternate day fasting (ADF) is the practice of fasting for one day, followed
by ad libitum consumption on the subsequent day. Although it has been documented that
individuals practicing ADF typically increase caloric intake on the feeding days, net calorie
ingestion is typically lowered over the total duration of the regime (27).
For many individuals, CR is intolerable for extended periods of time. Dietary restriction
(DR) may be more tolerable to these individuals. DR is a dietary modification in which an
individual reduces or eliminates the consumption of specific dietary components (28). DR
commonly involves the reduction of a specific macronutrient (carbohydrates, lipids, or proteins).
Vegetarian diets, ketogenic diets, and the Daniel Fast (DF) are examples of DR. The DF is a
religiously motivated DR, derived from the Bible. As described in the book of Daniel, the DF is a
strict vegan diet, consisting of only of pulse (food grown from seeds) (29). Today, a typical DF
consists of the ad libitum consumption of vegetables, whole grains, nuts, legumes, seeds, and
healthy oils. It prohibits the consumption of processed foods, coffee, and alcohol. Individuals
typically partake in the DF for 21-day periods.
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Time-restricted feeding, alternate day fasting, and the Daniel Fast have been shown to
improve many markers of health and longevity (29-31). However, relative to caloric restriction,
time-restricted feeding, alternate day fasting, and the Daniel Fast have not been studied in great
detail, especially with regard to changes in body composition and physical fitness (e.g., endurance
capacity). Because body composition and physical fitness are important markers of overall health,
it is important to compare TRF, ADF, and DF in a single study to determine the relative
effectiveness of each dietary modification these outcomes. To the author’s knowledge, no such
study has been conducted.
This review will discuss the relevant literature regarding TRF, ADF, and DF and the health
benefits associated with each. It will also discuss measures of body composition and physical
fitness and their relation to overall health and TRF, ADF, and DF.
Body Composition
The term “body composition” describes the chemical composition of the body. The human
body is composed of muscle mass, connective tissue, organs, bone, adipose tissue, and water.
Because it is difficult to measure the contribution of each of these components to overall body
composition through traditional methods, conventional measurements of body composition often
group the components of the human body into two gross categories: fat mass (FM) and fat-free
mass (FFM). Muscle mass, connective tissue mass, organ mass, and bone mass are collectively
termed FFM, while all adipose tissue is termed FM. Assessments of body composition attempt to
measure the relative percentages of FFM and FM and are often expressed simply in terms of
percent fat-free mass (%FFM) versus percent fat mass (%FM).
Body composition can either be directly measured or estimated. Cadaver analysis and
diagnostic imaging (Computerized Axial Tomography [CAT scan], Magnetic Resonance Imaging
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[MRI], and dual-energy x-ray absorptiometry [DXA]) are the only methods currently available to
directly measure total body composition. Cadaver analysis is considered the gold standard of body
composition assessment, which is obviously restricted only to use in animal models (32). Thus,
diagnostic imaging is the best method for assessing body composition in living humans. Currently,
many investigators use DXA due to its validity and reliability (33). Body composition may also
be estimated through various methods, including bioelectrical impedance analysis (BIA),
densitometry (hydrostatic weighing, water displacement, air plethysmography), and
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counting. Moreover, anthropometric measurements such as waist circumference and skinfold
thickness measurements are often used in large populations to estimate body composition, as these
assessments are quick to perform and inexpensive. However, estimates of body composition are
typically, but not always, less reliable than diagnostic imagery (34).
Body Composition and Overall Health
Body composition an important indicator of overall health. A high percentage of FM (%
FM) is closely correlated to elevated BMI (1). In turn, elevated BMI is associated with a number
of negative health outcomes. Obese individuals (BMI ≥ 30 kg∙m-2) present with increased CVD
risk factors, including hypertension, dyslipidemia, insulin resistance, and type II diabetes mellitus
(14). Ultimately, an increase in CVD risk factors leads to increased incidence of CVD-related
events in obese individuals, such as myocardial infarction, heart failure, sudden death, coronary
heart disease, and ischemic stroke (14, 35, 36).
Abdominal obesity, or visceral obesity, is another important measurement of body
composition. Measured by DXA and CT scan, or estimated via waist circumference, abdominal
obesity has been linked to a number of adverse outcomes, including increased risk of mortality,
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myocardial infarction, and heart failure (37). Weight loss strategies that reduce abdominal obesity
should be prioritized.
FFM can also be an important indicator of overall health because FFM is the single best
predictor of resting metabolic rate (38). Resting metabolic rate (RMR) - a measurement of resting
energy expenditure - accounts for 60-70% of total daily caloric expenditure, depending on physical
activity (39). Because energy expenditure must exceed energy intake to induce weight loss, RMR
and its influence on energy homeostasis should be considered in models of weight loss. Indeed,
researchers have hypothesized that abnormally low RMR is a strong indicator of future weight
gain (40). It has been known for some time that FFM is the single best predictor of RMR (38). In
fact, FFM explains between 60-80% of the variance in measured RMR (41). Additional
adjustments for specific components of FFM such as organ volume and density can push this R2
value to as high as 85% (42, 43). Thus, dietary interventions that result in weight loss but maintain
FFM should be prioritized.
Body Composition and Physical Fitness
Body composition is an independent predictor of physical fitness. Tests of physical fitness
often involve moving one’s body (i.e. running) as long or as fast as possible. FFM (skeletal muscle)
performs the work during such tests. Underweight individuals (BMI < 18 kg∙m-2) with low levels
of FFM may display worse fitness than normal weight individuals (6). Because FM is not
responsible for performing human work, FM may be viewed as “dead weight” during physical
activity. Individuals must simply carry this extra weight during physical fitness tasks and
examinations, similar to wearing a backpack while running. For obvious reasons, it is logical that
increased FM will have a detrimental impact on physical performance/fitness. Indeed, physical
fitness is negatively correlated with BMI in adolescents aged 12-18 years (6), as well as in young
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adults (7, 8). Additionally, studies have shown a negative correlation between body fatness and
performance in activities requiring running or jumping (44, 45). Therefore, generally, it can be
said that individuals with abnormally high or low BMIs may display lower fitness than individuals
of normal BMI.
Body Composition and Dietary Modification
Body composition can be altered significantly through dietary modification. Certainly,
many dietary modifications have been created for the sole purpose of decreasing total body mass
and FM. Caloric restriction has been shown to positively change body composition by decreasing
total body mass and FM (46, 47). Additionally, studies have reported that CR decreases abdominal
subcutaneous (48), visceral (48, 49), and intermuscular fat (48, 49). However, studies have also
indicated that CR significantly decreases FFM (49). For this reason, CR interventions may
recommend consumption of a high-protein diet. CR with a high protein diet shows promise in
maintaining FFM during CR-induced weight loss (50), although it should be understood that
reducing caloric intake will almost certainly lead to some loss in FFM.
TRF also displays the potential to reduce total body mass and FM while maintaining FFM.
To the author’s knowledge, three studies have examined the relationship between TRF and body
composition in humans. One study failed to report significant differences in total body mass, FM,
or FFM following a TRF intervention (51), while the other two studies reported extremely
favorable body composition outcomes (52, 53). The most successful study found that participants
in the TRF group lost significantly more FM compared to the control group when measured at the
conclusion of the 8-week intervention (−16.4 in TRF vs −2.8 %FM in control). Moreover, despite
losing significantly more FM, the TRF group did not differ from baseline or between groups for
FFM (+0.86 in TRF vs +0.64 %FFM in control) (53). It should be noted that, though existing
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evidence suggests that TRF is successful in maintaining FFM during weight loss, no studies have
measured body composition in overweight or obese individuals following TRF.
Relative to simple CR, ADF also seems to have the potential to induce favorable changes
in body composition in humans. Similar to simple CR, ADF has been shown to result in significant
reductions in FM (54-59), visceral FM (58), and waist circumference (57, 60). However, whereas
simple CR often results in loss of FFM, modified ADFs have demonstrated the ability to maintain
FFM during weight loss. Three out of four studies that have measured FFM have reported no
significant reductions in FFM relative to baseline (55, 57) or relative to a control group (56)
following the completion of a modified ADF protocol. It should be noted that while individuals
appear to retain FFM relatively well during modified ADF, traditional ADF has resulted in
significant reductions in FFM during ADF (54, 59).
Alternatively, DF has not resulted in favorable body composition alterations in humans.
Only one study has displayed significant reductions in total body mass and/or FM (61). Following
a 21-day DF intervention with krill oil supplementation, body weight (74.1 ± 2.4 versus 71.5 ± 2.3
kg), fat mass (21.9 ± 1.5 versus 20.8 ± 1.5 kg), and fat-free mass (52.2 ± 2.0 versus 50.8 ± 1.9) all
decreased significantly, relative to baseline. However, neither a traditional DF or a modified DF
(inclusion of one serving of meat and one serving of dairy per day) has resulted in significant
reductions in any measure of body composition (29, 62, 63). The lack of findings of significant
weight loss in these studies is likely due to the short duration of the intervention (21 days).
Physical Fitness
Generally, physical fitness is defined as the ability to perform physical activity (64). It is
characterized by a number of subcategories, including cardiorespiratory fitness, muscular fitness,
flexibility, balance, and speed. Physical fitness exists on a spectrum, with individuals being
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classified anywhere from low fitness to highest fitness based on performance in a number of
physical performance examinations (65). Many intrinsic factors such as age, sex, race, motivation,
and genetic expression influence physical fitness. Extrinsic factors also influence physical fitness,
most notably regular physical exercise (66).
Cardiorespiratory fitness and muscular fitness are the most important components of
health-related physical fitness. Cardiorespiratory fitness (CRF) is broadly defined as the overall
combined ability of the body’s cardiovascular and respiratory systems to uptake, transport, and
use oxygen (67). The most accurate measure of CRF is maximal oxygen uptake during an exercise
performance test (VO2max) (68). Measurements of VO2max can either be obtained directly or
indirectly. Direct measurement of VO2max involves the collection of an individual’s expired gases
using the Douglas Bag method or automated gas-collection equipment such as a metabolic cart.
The composition of the expired gas is analyzed to determine total oxygen uptake at the point of
volitional failure. Indirect measurement of VO2max involves the estimation of VO2max using an
exercise test. Graded exercise tests, such as a step-up test or a submaximal walk test, are frequently
used in clinical settings. A variable (i.e. time or heart rate) is measured upon the completion of the
exercise test. The value of this variable is then plugged into an adjusted equation to estimate
VO2max. Other exercise tests, such as the 1.5 mile run test and the run-time-to-exhaustion test,
provide meaningful descriptive data related to CRF.
Muscular fitness is characterized by the strength and endurance of skeletal muscle. A
variety of tests have been used to assess muscular fitness. These tests include maximal pushups
achieved during a given time frame, maximal sit-ups achieved during a given time frame, maximal
grip strength as measured by a hand dynamometer, and maximal weight achieved during resistance
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exercise (i.e. bench press). Studies have not determined a single test of muscular capacity that best
estimates overall muscular fitness.
Physical Fitness and Overall Health
Studies have routinely reported CRF to be an important predictor in overall health for a
multitude of populations. Low CRF leads to decreased ability to perform seemingly-simple daily
activities. Additionally, low CRF appears to be a powerful independent risk factor for all-cause
mortality in both healthy and non-healthy populations (65, 69-71). Studies have also shown an
inverse relationship between CRF and the risk of developing sudden cardiac death (72), cancer
mortality (73), childhood obesity (74, 75), type 2 diabetes mellitus (76, 77), and cardiovascular
disease (78). Similarly, studies have reported a positive relationship between CRF and cognition
(79) and health-related quality of life (80).
Because low CRF is associated with adverse outcomes and high CRF is associated with
positive outcomes, improving CRF is perhaps the most important fitness goal for the average
individual. Fortunately, studies have repeatedly demonstrated that regular exercise improves CRF
(66, 81). Moreover, drastic improvements in CRF may not be required to induce clinically
meaningful improvements in health-related outcomes, as indicated by Kokkinos et al. In one study
conducted by Kokkinos et al., they examined the relationship between CRF and mortality risk in
6,749 black and 8,911 white men. CRF was measured in metabolic equivalents (METs) (65). One
MET was defined as the energy expended at rest by an average individual (estimated to be 3.5
mL∙kg-1∙min-1). The study reported that a 1-MET increase in exercise capacity resulted in a 13%
reduction in risk of mortality for individuals with and without cardiovascular disease. Small
improvements such as these may also lead to increased ability to perform basic daily tasks,
especially in older adults.
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Compared to CRF, research on the role of muscular fitness and overall health is limited.
Muscular fitness is important for maintaining individual autonomy (82). Simple tests of muscular
fitness such as the sit-stand provide valuable indicators of an individual’s functional muscular
fitness. Individuals that perform extremely poorly on these functional fitness exams will likely
experience difficulty performing everyday tasks, a general characteristic of extreme obesity.
Moreover, muscular fitness may be an important indicator of general health. Muscular fitness has
been inversely linked to several adverse outcomes, including all-cause mortality (83, 84) and
premature death (85).Therefore, improving muscular fitness should also be a goal for all
individuals.
As mentioned above, physical fitness is closely associated with body composition which
is also associated with overall health. Underweight individuals (BMI < 18 kg∙m-2) may be less fit
than normal weight individuals (6, 86). On the other end of the spectrum, high BMI has been
associated with poor physical fitness (6-8). To maximize most measures of physical performance,
individuals should strive to maintain normal body weight and health levels of FM.
Physical Fitness and Dietary Modification
Diet plays a major role in physical fitness. Relative to ad libitum feeding, CR appears to
improve physical performance in mice (87, 88), likely because weight gain is inversely related to
physical performance (6). High-carbohydrate diets have been recommended for prime physical
performance because they are said to keep glycogen stores saturated and blood concentrations of
triacylglycerides and free-fatty acids low (89, 90). Two recent reviews indicated that consumption
of a high-fat diet may result in diminished physical performance, especially at high intensities and
in anaerobic conditions (91, 92). Therefore, it appears that a high-carbohydrate diet augments
performance when compared to a high-fat diet.
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Few studies have examined the effects of DF, ADF, or TRF on physical performance. To
date, only one study has examined the relationship of the DF and physical fitness. Following the
conclusion of a 3-month DF and exercise intervention in male rats, cardiorespiratory fitness was
measured (run-time-to-exhaustion) and compared to baseline fitness (Bloomer, In Publication).
Exercise capacity increased significantly more (99% increase) in the DF + exercise group when
compared to the WD + exercise group (51% increase), indicating that the DF accentuated exercise
gains. To this author’s knowledge, only 3 studies (excluding studies that focused on Ramadan)
have examined the relationship of TRF and physical fitness. Two studies have tested the effects of
TRF in humans. Both of these studies utilized 8-week interventions and similar intervention groups
(TRF + resistance training 3 x weekly) and control groups (normal diet + resistance training 3 x
weekly) (51, 53). Neither study reported significant differences between groups in physical
performance as measured by muscular strength or endurance (51, 53). One study examined the
effects of TRF on physical performance in animals. This study reported that Drosophila subjected
to TRF displayed significantly better flying performance, relative to the control group (93). No
publications have studied ADF and physical fitness. More research is needed in humans and
animals to determine whether TRF, ADF, and DF will enhance physical fitness.
Time-Restricted Feeding
Intermittent fasting (IF) is a general term that describes any dietary modification in which
an individual intentionally alternates between periods of “feeding” and extended, self-induced
“fasting” (26). During the feeding period, individuals are often permitted to consume foods ad
libitum (51, 59, 94), although some IF interventions have restricted caloric intake during the
feeding period (53, 95). During the fasting period, individuals either abstain from caloric intake
all together (51, 52, 96) or dramatically reduce caloric intake by 70-80% (56, 97, 98). Fasting
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periods can last anywhere from 12 hours (99) to 48 hours (97) or longer, and the duration of this
period typically demarcates the classification of each IF regime. Recently, two types of IF have
recently garnered noteworthy interest from the scientific community.
In recent decades, alternate day fasting (ADF) and time-restricted feeding (TRF), two
specific types of IF, have gained scientific momentum. ADF involves the cycling of 24-hour ad
libitum feeding with 24-hour fasting or severe caloric restriction (26). Alternatively, TRF – the
topic of this section - simply involves the daily reduction of the feeding period. Typical TRF
interventions limit the daily feeding period to a 4-12 hour window in the afternoon/evening,
eliminating any caloric consumption during the morning and night hours. This results in a
lengthened fasting period (12-20 hours per day). However, during feeding periods, individuals are
allowed ad libitum caloric consumption. Additionally, TRF does not necessarily mandate that
individuals “improve” their diet, only alter their meal timing. For these reasons, TRF is viewed as
a very user-friendly alternative to individuals who find it difficult to adhere to the guidelines of
simple CR.
Time-Restricted Feeding: Overview of Current Literature
Human Trials
Few publications have examined the effects of controlled TRF interventions in a human
model. However, despite utilizing short-term TRF interventions lasting between 2-8 weeks and
some conflicting results, these studies have displayed promise. Many benefits have been associated
with TRF, including - but not limited to – reduction of caloric intake (51), weight loss (52, 53),
decreased FM (52, 53). Positive alterations in blood lipids following TRF such as increased HDL
(52) and decreased triglycerides (53) have been noted. Additionally, TRF has been associated with
decreased blood glucose and decreased blood insulin (53). Studies examining the effects of
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Ramadan-fasting-induced TRF have reported similar positive results (100-104). Furthermore,
studies indicate that TRF, especially 16/8 (16 hour fasting period/8 hour feeding period) TRF, is
well tolerated by participants (53).
Currently, few negative or conflicting results have been reported in regards to TRF. Carlson
and colleagues stated that an 8-week TRF intervention (1 iso-caloric [relative to control group]
meal per day consumed between 5:00pm – 9:00pm) resulted in increased morning blood glucose
concentrations and decreased glucose tolerance (105). The authors suggested that the increase in
blood glucose levels could be a result of the study’s design, stating that early-morning blood
glucose levels were likely impacted by the consumption of extremely calorically dense
intervention meal the during the preceding night. The duration of period may have also influenced
this outcome. Longer feeding periods (6-8 hours) may improve measures of glucoregulation, as
displayed by the findings of Moro et al. (53). Additionally, Tinsley et al. indicated that an 8-week
TRF intervention (4-hour ad libitum feeding period between 4:00pm – 8:00pm) may lead to
decreased hypertrophic gains in untrained males relative to untrained males following the same
resistance training protocol but consuming food ad libitum (51). Thus, TRF may not be appropriate
in the early stages of resistance training when hypertrophy is the main goal. However, it should be
noted that TRF has been reported to maintain FFM during weight loss and resistance training (5153).
Animal Trials
Animal trials have largely corroborated many of the beneficial findings of human trials
discussed above. TRF in animals appears to be an effective method for preventing weight gain
and/or inducing weight loss in a number of species, including Drosophila (93), mice (99, 106110), rats (111) and geese (112). Notably, evidence suggests that weight loss and/or prevention of
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weight gain can be achieved through TRF despite consumption of at high-fat diet (99, 107). Studies
have indicated that TRF is successful in improving important lipid factors, such as lowering total
cholesterol (107, 108, 113) and triglycerides (107, 109). TRF has also been noted to improve
glucoregulatory factors by lowering plasma insulin levels and increasing insulin sensitivity (107,
108). Studies have also reported diminished levels of inflammatory markers following TRF (107,
108).
It should be noted that not all animal trials have yielded exclusively positive results. Some
studies have failed to report differences in weight gain post-TRF, relative to a control group (114,
115). Additionally, not all studies have demonstrated significant improvements in glucoregulatory
factors following TRF (115). In fact, Park et al. stated that TRF exacerbated hepatic insulin
resistance, despite loss of FM, in hormone-sensitive lipase knockout mice (115). These discrepant
results may be the result of a number of factors. In some cases, small sample sizes may have limited
statistical power, diminishing the opportunity to find significant differences between groups (114).
In other cases, differences in reported outcomes may be attributed to differences is protocols, as
studies have used various animal models (i.e. hormone-sensitive lipase knockout mice vs wildtype mice), interventions of differing lengths (i.e. a 4-week intervention v. a 12-week intervention),
and daily feeding periods of differing lengths (i.e. a 4-hour feeding period versus a 12-hour feeding
period).
Time-Restricted Feeding and Physical Fitness
Human Trials
Two studies have examined the effects of TRF on physical fitness in humans, both utilizing
tests of muscular fitness. Tinsley and colleagues utilized an 8-week TRF in combination with
resistance training in young, normal-weight, untrained males (n = 18) (51). The intervention group
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consumed a modified TRF diet, while the control group continued to consume their normal diet
throughout the duration of the study. Both the control group and the intervention group completed
resistance training (8-12 repetitions to failure) on non-consecutive days 3 x weekly, alternating
between lower-body and upper-body sessions. Maximal muscular output – classified by maximal
muscular strength and maximal muscular endurance – was measured at base-line and postintervention. Maximal strength was defined by maximal weight achieved during 1-repetition
(1RM) during the hip sled and barbell bench press exercises. Muscular endurance was defined by
maximal repetitions using a standardized weight during the hip sled and barbell bench press
exercises. Relative to baseline, hip-sled endurance, bench-press endurance, and hip sled strength
increased, post-study. However, no differences existed between groups.
A second study focused on TRF in resistance-trained men (n = 34). Moro and colleagues
implemented a 16/8 TRF intervention (16 fasting period; 8 hour feeding period between 1:00pm9:00pm; meals consumed at 1:00pm, 4:00pm, and 8:00pm) in combination with 3 x weekly
resistance training (split routine; 6-8 repetitions to failure) (53). The control group was instructed
to consume meals at standard times (1:00pm, 4:00pm, and 8:00pm) in combination with 3 x weekly
resistance training (split routine; 6-8 repetitions to failure). Muscular strength was measured at
baseline and post-intervention. Muscular strength was defined as 1RM achieved during leg press
and bench press exercises. Moro et al. reported that weight achieved during 1RM for leg press
increased in both groups, relative to baseline. However, no differences existed between groups.
1RM achieved during bench press did not differ from baseline or between groups.
Taken together, these studies indicate that short-term TRF interventions do not inhibit
anaerobic muscular performance during resistance training. These data are generally supported by
similar studies that have examined the relationship between performance and TRF during
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Ramadan (116). More research is needed in this area to verify that TRF does not inhibit, or
preferably improves, physical performance. Additional studies should also focus on measures of
CRF.
Animal Trials
To the author’s knowledge, only one animal study has included any physical performance
measure following TRF. Gill et al. indicated that 5 weeks of 12-hour TRF in wild type Drosophila
significantly improved ability to fly, as measured by flight index (93). However, the study failed
to specify how or when flight performance was measured. Additionally, the researchers did not
mention the specifics of the flight index that was used. Because of the lack of detail provided in
the paper of Gill and coworkers and the fact that no other studies are available in this area, more
studies are needed to better understand the potential influence of TRF on physical performance in
animals.
TRF and Body Composition
Human Trials
To the author’s knowledge, three studies have examined the relationship between TRF and
body composition. One study reported moderately favorable body composition outcomes, while
the other two studies reported extremely favorable body composition outcomes. The two studies
described above in the TRF section reported measures of body composition in addition to the
aforementioned measures of muscular performance. Tinsley et al. measured body composition via
DXA (51). No significant differences existed relative to baseline or between groups for total body
mass, FFM, or FM. However, the study did state that, though the difference was not significant,
FFM increased in the control group (+2.3 kg FFM) and decreased in the TRF group (-0.2 kg FFM).
The researchers mentioned that the non-significant difference in FFM gains between groups could
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most likely be attributed to the training status of the participants (i.e. untrained) and the caloric
demand associated with hypertrophy during the onset of training.
Alternatively, Moro and colleagues reported very promising results. They used DXA to
measure body composition at baseline and post-intervention (53). The study indicated that
participants in the TRF group (10.90 ± 3.51 kg at baseline versus 9.28 ± 2.47 kg post-intervention)
lost significantly more FM compared to the control group (11.36 ± 4.5 kg at baseline versus 11.05
± 4.27 kg post-intervention). The TRF group also experienced greater reductions in %FM relative
to the control group (−16.4 % FM in TRF vs −2.8 % in control). However, despite losing
significantly more FM than individuals in the control group, individuals in the TRF group (73.08
± 3.88 kg at baseline versus 73.72 ± 4.27 kg post-intervention) did not exhibit significantly
different levels of FFM post-intervention when compared to baseline or the control group (73.93
± 3.9 kg at baseline versus 74.41 ± 3.59 kg post-intervention). Additionally, measurements of midarm circumference and mid-thigh circumference did not differ between groups or from baseline
for either condition.
A third study examined the effects of an 8-week 20/4 (20-hour feeding period, 4-hour
fasting period) TRF intervention on body composition in normal-weight, middle-aged adults (n =
15) (52). All meals were provided by the lab staff, and caloric intake did not differ between the
control condition (3 meals daily) and the intervention condition (all food consumed between
5:00pm – 9:00pm). Body composition was assessed via BIA at baseline and post-intervention.
Favorable changes in body composition were exhibited post-intervention. Relative to the control
condition, the TRF condition exhibited significantly greater weight loss (1.4 kg) and reduction of
FM (2.1 kg). No differences were observed between-groups for FFM. Additionally, none of the
body-composition measures differed significantly relative to baseline.
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No studies have measured body composition in overweight or obese individuals following
TRF. However, the evidence discussed in this section shows that similar individuals can achieve
loss of FM and retention of FFM through TRF. Further studies should apply these findings to an
obese sample to ascertain if similar alterations in body composition are attainable through TRF.
Animal Trials
A majority of animal trials that have reported body composition have indicated that TRF
has a major impact on body mass and FM. Studies show that mice fed during the dark phase (active
phase) display significantly lower total body mass and lower total FM and %FM when compared
with mice fed ad libitum or during the light (inactive) phase (99, 108, 117, 118). Notably, this
reduction appears to occur independent of diet composition. Studies have demonstrated that mice
fed a high fat diet during the dark phase display lower %FM relative to controls (107, 108). No
studies have described alterations in FFM or %FFM following TRF. More research is needed to
determine how TRF affects FFM in animals.
Alternate Day Fasting
Alternate day fasting (ADF) is a type of IF protocol that has received increased attention
from members of the scientific community over the past decade. ADF regimes consist of
alternating “feed” and “fast” days, often grouped in 14-day cycles. For example, ADF protocols
should be arranged such that individuals experience 7 fast days and 7 feed days over a given 14day period. Feed days typically consist of ad libitum caloric consumption (27), although at least
one study has implemented a caloric limit on feed days (60). Fast days involve either total or severe
caloric restriction. ADF interventions that eliminate caloric intake for the entire 24-hour period are
considered traditional ADFs (54, 59). Traditional ADFs may permit consumption of calorie free
beverages and/or calorie-negligible options such as bouillon/stock cube soup (59). ADF
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interventions that allow for consumption of a small meal on fast days are termed modified ADFs.
(56, 57). Modified ADFs typically permit consumption of 1 small meal on fast days in an effort to
depress feelings of hunger on fast days and, ultimately, attrition rates. These meals typically consist
of 25-30% of normal daily caloric consumption and are typically consumed in the early afternoon
(55, 94), though evidence has suggested that meal timing on fast days does not impact outcomes
(58).
Alternate Day Fasting: Overview of Current Literature
Human Trials
The benefits of ADF in humans have been well-documented. Thus far, studies have
primarily focused on ADF in obese populations (56), although some trials have included normalweight and over-weight participants (54, 56). Many of these publications have utilized a modified
ADF intervention (55, 58, 60, 119, 120), while relatively few studies have implemented a
traditional ADF in humans (54, 59). Additionally, although most studies have utilized short-term
(2-12 week) ADF interventions, the results have been encouraging.
Generally, human trials have reported improved health-related outcomes following ADF.
Studies have repeatedly shown that ADF is effective for inducing weight loss in both obese (55,
57-60, 121, 122) and non-obese individuals (54-56), while resulting in favorable changes in body
composition (these variables will be discussed in further detail below) (57, 59). Additionally, ADF
has been associated with improved measures of cardio-metabolic health, including decreased
cholesterol (56, 59, 98), decreased LDL levels (56, 59, 98), decreased triglyceride levels (56, 59,
98), and decreased blood pressure (56, 57, 60). These cardiovascular-health-related benefits of
ADF may be further enhanced when combined with an exercise intervention (57). Furthermore,
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one study has also shown that markers of inflammation and oxidative stress may be improved
following ADF in obese individuals with asthma (122).
Some null or negative findings have been associated with ADF. One study failed to report
reductions in total body mass, likely due to the short duration of the 2-week intervention used (96).
Another study has indicated that short-term ADF can lead to unfavorable reductions in HDL levels
(59). Still others have indicated that ADF results in the loss of FFM (54, 59). Interestingly, all of
these undesirable outcomes have been reported following traditional ADF. Potentially, the total
elimination of any caloric intake on fast days of a traditional ADF leads to the development of
these adverse outcomes. Indeed, Heilbronn et al. address this notion in the discussion section of
their paper, hypothesizing that a modified ADF that allows for 10-20% of caloric needs on fast
days may lead to better outcomes (54). Thus, it is recommended that individuals undergo a
modified ADF for a period of at least 3 weeks for best clinical results.
Animal Trials
ADF interventions conducted in animal models have yielded positive results. Similar to
simple CR, ADF has been reported to protect against the development of several severe negative
health outcomes, such as diabetes, cancers, heart disease, and neurodegeneration (123). ADF has
also been associated with significant cardio-protection (124). Studies have indicated that ADF
favorably alters measures of cardiovascular health by lowing heart rate, blood pressure, blood
insulin, and blood glucose (125, 126). Moreover, ADF has been shown to induce weight loss and
prevent weight gain (125, 127-129), as well as decrease visceral fat mass (129, 130). Indeed,
weight loss appears to be achievable through ADF despite the consumption of a high fat diet (131).
Ultimately, these protective effects of ADF may result in increased longevity (132, 133).
ADF and Physical Fitness
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To the author’s knowledge, no studies have reported any measure of physical fitness or
physical performance with respect to ADF in humans or animals. However, because high FM and
low FFM are associated with decreased physical fitness and performance (7, 8), it is expected that
ADF would improve physical fitness and performance simply by improving body composition in
overweight and obese individuals and animals.
ADF and Body Composition
Human Trials
Relative to simple CR, ADF seems to have the potential to induce favorable changes in
body composition. Similar to simple CR, ADF has been shown to result in significant reductions
in FM (54-59), visceral FM (58), and waist circumference (57, 60). However, whereas simple CR
often results in loss of FFM, modified ADFs have demonstrated the ability to maintain FFM during
weight loss. Three out of four studies that have measured FFM have reported no significant
reductions in FFM relative to baseline (55, 57) or relative to a control group (56) following the
completion of a modified ADF protocol.
It should be noted that while individuals appear to retain FFM relatively well during
modified ADF, traditional ADF may result in significant reductions in FFM. The only two
traditional ADF trials in humans have reported significant decreases in FFM following
interventions of 3 (54) and 8 weeks, respectively (59). For this reason, modified ADFs are
recommended for optimizing loss of FM and retention of FFM during ADF.
Animal Trials
Interestingly, though many animal studies have reported ADF-induced weight loss, few
studies have investigated body composition following ADF, and these results are conflicting. Two
studies have found that ADF does not result in decreased fat mass. Varady et al. reported no
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significant difference in inguinal adipose mass or epididymal adipose mass following a 4-week
traditional ADF (32). A subsequent study also failed to report significant differences in fat mass
between control and ADF groups after 4 weeks of ADF (130). Only one study, conducted by
Dorighello et al., has reported successful reductions in total fat mass. This study indicated that a
12-week traditional ADF was successful in reducing epididymal fat pad mass in wild-type mice
(134). No studies have reported measures of total FFM.
While the literature has failed to support unequivocally the claim that ADF reduces fat
mass in animals, it should be noted that preliminary evidence has suggested that ADF can alter the
size and distribution of adipose cells in clinically meaningful ways. ADF has been shown to
favorably alter adipose tissue distribution by decreasing visceral fat mass and increasing
subcutaneous fat mass (130). Because visceral obesity has been linked to increased incidence of
insulin resistance, cardiovascular events and premature death, decreases in visceral fat mass are a
significant finding (130). Additionally, another study has indicated that ADF results in decreased
inguinal adipose cell size (32). This finding is important because large adipose cells have been
reported to increase the risk of developing chronic disease (130). So, while the evidence does not
yet fully support the notion that ADF leads to decreased total FM in animals, studies do suggest
that ADF favorably alters the composition and distribution of FM, a worthwhile outcome.
Dietary Restriction
Dietary restriction (DR) is a dietary modification in which an individual reduces or
eliminates the consumption of one or more specific dietary components (28). DR commonly
involves the reduction of a specific macronutrient (carbohydrates, lipids, or proteins), but other
dietary components may be the subject of DR. One such example is methionine (an essential amino
acid) restriction, which has been shown to lower the incidence of cancer and extend life spans in
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animal models (135). Though the primary goal of DR may not be calorie restriction, it typically
results in reduced caloric intake by default. The Daniel Fast is an example of a DR model that
typically leads to decrease in caloric consumption, relative to normal ad libitum calorie intake.
The Daniel Fast (DF) is a religious fast, derived from the Bible (29). Typically, individuals
partake in the DF for a 21-day period, as described in the book of Daniel. It is a strict vegan diet
that inherently leads to reduced caloric intake. Individuals participating in a DF may consume
fruits, vegetables, whole grains, nuts, legumes, seeds, and healthy oils (such as olive oil) ad libitum.
Products that contain additives or preservatives, as well as coffee and alcohol, are prohibited.
Because the DF involves ad libitum intake of the permitted foods, individuals may find it an easier
model to follow than other caloric restriction models.
Daniel Fast: Overview of Current Literature
Human Trials
Several studies have shown the Daniel Fast, followed for as few as 21 days, to improve
markers of health. All have been conducted at The University of Memphis. In the first such study
conducted, Bloomer and colleagues implemented a 21-day DF in 43 human participants (13 men;
30 women; 35 ± 1 yrs; range: 20-62 yrs) to assess its effects on metabolic and cardiovascular risk
factors (29). Participants were not excluded based on body mass. Thus, individuals with a variety
of BMIs enrolled in the study: 21 participants were considered to have a “normal” BMI (BMI <
25 kg∙m-2); 9 participants were considered overweight (BMI 25-29.9 kg∙m-2); and 13 participants
were considered obese (BMI > 30 kg∙m-2Participants were generally considered to be healthy
individuals. Thirty-four of 43 participants were considered exercise trained (participate in 3 hours
of anaerobic and aerobic exercise per week). A pretest was conducted for all tested variables before
the 21-day intervention was initiated. Post-intervention testing revealed that many important
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metabolic and cardiovascular markers of health had improved following the 21-day fast. Amongst
other variables, total cholesterol (171.07 ± 4.57 vs. 138.69 ± 4.39 mg·dL-1), systolic blood pressure
(SBP; 114.65 ± 2.34 vs. 105.93 ± 2.12 mmHg), and diastolic blood pressure (DBP; 72.23 ± 1.59
vs. 67.00 ± 1.43 mmHg) were significantly lowered when compared to baseline values (p < .05).
Additionally, insulin blood-concentrations and HOMA-IR scores were lowered (p > .05) by
clinically meaningful values. Moreover, total caloric intake was significantly reduced during the
intervention period when compared to baseline (2185 ± 94 vs. 1722 ± 85 kcals). The only noted
downside of the DF was a significant decrease in HDL-C. Thus, Bloomer et al. concluded that a
21-day DF can result in key metabolic changes that may improve overall health.
A year later, a subsequent study was published on the same data set which assessed
antioxidant status and markers of oxidative stress following a 21-day DF (136). Results showed
that a 21-day DF positively effects antioxidant status and markers of oxidative stress.
Concentrations of certain variables increased significantly (p < .05) post-intervention, including
Nitrate/Nitrite (NOx) and Trolox Equivalent Antioxidant Capacity (TEAC). Markers of oxidative
stress were reduced, post-intervention. Malondialdehyde (MDA) levels were significantly lowered
(p = .004) by 15%. H2O2 levels were also meaningfully lowered (p = .074) by 14%. Together,
these data indicate that a 21-day DF can lower levels of oxidative stress while raising levels of
antioxidants.
Subsequent studies have validated the majority of these results. In 2012, Bloomer et al.
conducted a 21-day DF on 22 participants to examine post-prandial oxidative stress. Ten men and
12 women (aged 35 ± 3 years) completed the study (62). Participants had a wide variety of BMIs
(13 normal, 4 overweight, and 5 obese). Bloomer and colleagues noted no significant decrease in
post-prandial oxidative stress. However, several health benefits were reported. Both DBP and SBP
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were lowered post-intervention. NOx increased following the DF (TEAC was not significantly
higher). Total caloric intake was lowered by 16% during the DF.
A modified DF has also been shown to produce meaningful health benefits (61, 63). A
modified DF is inclusive of dietary components that are excluded in a traditional DF. In a study
published in 2012, Trepanowski and colleagues instructed participants in the experimental group
to consume krill oil capsules (2 g/day in 2 daily dosages of 1 g) daily in an effort to maintain HDLC levels (61). While HDL-C levels were not significantly different between the control and
experimental groups, the litany of health benefits reported in the original study conducted by
Bloomer et al. in 2010 were observed. Similarly, Alleman and colleagues reported a significant
decrease in HDL-C following a 21-day DF modified to include one serving of lean meat (3 oz.)
and dairy (8 oz. skim milk) per day (63).
Animal Trials
To date, two studies have implemented a DF intervention in an animal model. Bloomer et
al. utilized a 3-month DF intervention in male Long-Evans rats (n=60) to determine the effects of
the DF on physical performance, body composition, blood lipids, oxidative stress and
inflammation (Bloomer, unpublished). Following a 2-week acclimation period, animals were
assigned to an exercise group and a diet group. Two exercise groups existed, with animals either
being assigned to the exercise-trained group (E), which exercised 3 times weekly on a treadmill,
or the sedentary group, which was only permitted normal daily activity. Two diet groups were
used, with animals either assigned to an ad libitum WD group or an ad libitum DF group. At the
conclusion of the study, DF rats displayed relatively lower body mass, cholesterol, triglycerides,
lipid peroxidation, and protein oxidation than WD rats. Additionally, rats in the DF+E group
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displayed greater physical performance increases, relative to the WD+E group. Markers of
inflammation did not differ between groups.
In a separate publication, Daniels et al. detailed how the intervention described above
affected the rats’ viscera, particularly the small intestine. Daniels et al. reported several key
findings. Following the 13-week intervention, WD rats had heavier livers than DF rats (25.9 ± 2.0
kg versus 17.1 ± 0.6 kg). The intestines of the WD rats were shorter when compared to the DF
rats’ intestines. The weight of the WD rats’ intestines represented a smaller percentage of total
body weight (g∙kg-1 body weight) than the intestines of the DF mice. The WD rats intestines
displayed shallower crypts and narrower villi, compared to the DF rats’ intestines. These results
are likely the result of the low fat, high fiber composition of the DF diet and indicate that the small
intestines of DF rats adapted to become more absorptive per kg of body weight compared to the
WD rats’ small intestines.
Daniel Fast and Physical Performance
Human Trials
No human trials have tested physical fitness following DF. However, many subjects have
commented that they “feel” better physically when following the DF eating plan. Of course,
quantitative data are needed to confirm improvements in performance.
Animal Trials
To date, only one study has examined the relationship of the DF and physical fitness. This
study utilized a 3-month DF intervention in male Long-Evans rats to determine the effects of the
DF on physical performance (Bloomer, unpublished). Baseline cardiorespiratory capacity was
measured for all animals as run time to exhaustion. Following the conclusion 3-month intervention,
cardiorespiratory fitness was measured again. Exercise capacity significantly increased for both

54

exercise groups, relative to baseline. However, exercise capacity increased significantly more
(99% increase) in the DF + E when compared to the WD + E group (51% increase), indicating that
the DF increased exercise gains independent of body mass.
Daniel Fast and Body Composition
Human Trials
To date, the DF has not resulted in consistent and favorable body composition alterations
in humans but has resulted in a mean weight loss of approximately 4-6 pounds over a three week
intervention period. Only one study has displayed significant reductions in total body mass and/or
FM (61). Following a 21-day DF intervention with krill oil supplementation, body weight (74.1 ±
2.4 versus 71.5 ± 2.3 kg), fat mass (21.9 ± 1.5 versus 20.8 ± 1.5 kg), and fat-free mass (52.2 ± 2.0
versus 50.8 ± 1.9) all decreased significantly, relative to baseline. However, other studies, using
either a traditional DF or a modified DF (inclusion of one serving of meat and one serving of dairy
per day), have not reported significant improvements in any measure of body composition (29, 62,
63). Two traditional DF studies have reported measures of body composition. The first traditional
DF study indicated that total body mass (77.5 ± 3.0 versus 74.7 ± 2.7 kg), %FM (30.2 ± 1.6 versus
29.9 ± 1.6%), %FFM (53.8 ± 2.0 versus 52.1 ± 1.9%), and waist circumference (92.2 ± 2.0 versus
90.4 ± 2.0 cm) remained unchanged at the conclusion of the 21-day intervention (29). Similarly,
the second traditional DF study reported that body mass (77.8 ± 3.8 versus 75.1 ± 3.5 kg), FM
(21.1 ± 2.2 versus 19.9 ± 2.1 kg), %FM (26.7 ± 2.3 versus 26.1 ± 2.1%), FFM (56.7 ± 2.8 versus
55.2 ± 2.7 kg), and waist circumference (88.7 ± 2.9 versus 87.5 ± 2.9 cm) remained unchanged at
the conclusion of the 21-day intervention (62) . A DF modified to include meat and dairy also
reported no changes in body composition following 21 days of DF, including no changes in total
body mass in the traditional DF group (81.7 ± 4.8 versus 79.3 ± 4.9 kg) or in the modified DF
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group (74.5 ± 6.1 versus 72.4 ± 5.7 kg); no changes in %FM in the traditional DF group (35.7 ±
2.4 versus 35.5 ± 2.5%) or in the modified DF group (33.8 ± 3.5 versus 33.4 ± 3.6%); and no
changes in %FFM in the traditional DF or the modified DF group (63). The lack of findings of
statistically significant weight loss in these studies is likely due to the short duration of the
intervention (21 days) and the variability in subjects’ response.

Animal Trials
The animal trial discussed above in Daniel Fast and Physical Fitness also reported
measures of body composition. The data indicated that DF is effective in preventing weight gain
in rats, relative to ad libitum feeding (Bloomer, unpublished). Rats in the WD group (571.1 ± 14.7
kg) weighed significantly more post-intervention than all other groups (516.8 ± 10.7 kg WD + E;
478.7 ± 11.3 kg DF + E; 496.8 ± 13.5 kg DF). Additionally, rats in the DF groups weighed
significantly less than rats in the WD groups (data not given). Bloomer et al. also reported a group
effect for %FM. Both DF groups (20.3 ± 1.3% DF + E; 24.6 ± 1.4% DF) displayed lower %FM
than both WD groups (30.6 ± 1.3% WD + E; 33.5 ± 1.0% WD). Furthermore, no significant
between-group differences were noted for FFM (366.0 ± 9.2 kg WD + E; 386.8 ± 6.7 kg WD;
391.4 ± 8.8 kg DF +E; 376.5 ± 7.8 kg DF), indicating that the DF may be effective in attenuating
FFM loss in animals.
Conclusion
Obesity is a multifactorial disease that presents myriad problems, both in the United States
and worldwide. It is associated with increased risk of chronic, and potentially fatal, disease, such
as cardiovascular disease, heart attack, and suddent death (14). Additionally, obesity places a major
financial burden on the individual and the United States healthcare system (4). Thus, attenuating
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the rise of obesity worldwide is a primary goal of many healthcare organizations, such as the World
Health Organization. This goal may be achieved through dietary modification.
Though more research is needed, three novel dietary interventions – time-restricted
feeding, alternate day fasting, and the Daniel fast – appear able to successfully induce weight loss,
while simultaneously generating additional positive health outcomes. However, each one of these
dietary modifications currently displays unique benefits. TRF causes the most favorable changes
in body composition. While studies have linked DF and ADF to insignificant or unfavorable
alterations in body composition, studies generally show that TRF leads to significant reductions in
FM (52, 53, 99) without reducing FFM (52, 53). Additionally, because TRF permits the daily
consumption of a high-fat diet, it has an added psychological benefit, relative to ADF (which
severely restricts caloric intake every other day) and DF (which eliminates processed foods).
Conversely, ADF is the only dietary modification out of the three that has been shown to
consistently reduce total body mass in a significant manner. Varady et al. and others have
repeatedly demonstrated that ADF results in significant reductions of total body mass (54-56, 59).
TRF and DF have yet to consistently demonstrate large improvements in weight, though TRF has
not been utilized in an obese sample, and DF studies have yet to span longer than 3 weeks in
humans. DF appears to be the most comprehensive dietary modification, compared to TRF and
ADF. DF studies have shown improvements in virtually every health-related factor, despite shortterm interventions (29, 61, 63, 136). Additionally, DF is the only dietary modification that has
been shown to increase physical performance (Bloomer, unpublished).
Despite the promising results of the literature detailed above, much still needs to be learned
about these dietary modifications. Little literature has been published on DF and TRF, and few of
these studies have reported measures of body composition or physical performance, essential
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indicators of overall health. Moreover, no studies have implemented TRF, ADF, and DF in the
same study to compare outcomes of each dietary modification. Thus, a single study comparing
TRF, ADF, and DF is needed to determine the relative effectiveness of these dietary modifications
on body composition and physical performance.
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IACUC Protocol Action Form
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IACUC PROTOCOL
FOR USE OF LIVE VERTEBRATES FOR RESEARCH, TEACHING OR DEMONSTRATION

UNIVERSITY OF MEMPHIS
5/3/17

Date submitted to Attending Veterinarian for pre-review:
5/30/17

0806
IACUC Protocol #

Date Submitted to IACUC
7/1/17

Dates Protocol will be in effect:

from

6/30/20
to

(not to exceed three years including two yearly renewals)

Is this protocol related to an external grant or contract application?

Yes

No

If yes, complete the following:

Agency:

Date Submitted

Grant #

University account for Animal Care Facility per diem charge:

If the protocol is not related to an external grant or contract application, complete the
following:
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211700
University account for Animal Care Facility per diem charge:

Project Title: (If project relates to a grant or contract application, give that title; if multiple
protocols relate to one grant, give unique titles for each protocol; if the project is related to a
class, give the course name and number):

Impact of dietary and caloric restriction models on metabolic health and physical function in
male mice

I.

Personnel
Marie van der Merwe and Richard Bloomer

Investigator/Instructor:
Health Studies
Department:
Assistant Professor and Professor
Academic Rank:

Campus phone:

678 3476 and 678 5638

Emergency phone:

901 406 7458 / 901 267 3514

Karyl Buddington
Attending Veterinarian:

Phone:

901-678-2359

Emergency phone: 901-258-1232
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List all individuals that will handle animals using this protocol, their affiliation, and their level of
expertise (e.g. relevant qualifications). If the protocol applies to a class then so specify.
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Marie van der Merwe, PhD (Molecular Pharmacology), Postdoctoral Fellowship (Bone
Marrow Transplantation): More than 10 years of experience using mice as a research
model.

Richard Bloomer, PhD: 2 years of prior experience using rodents in research.

Melissa Puppa, PhD: 8+ years of experience working with mice including breeding,
exercise training/testing, injections, surgery, dietary interventions, gavage, GTT,
electroporation, blood collection, and dissection/necropsy.
Matt Butawan: 2 years of rodent handling experience.
Harold Lee: 1 year of rodent handling experience, including exercise testing (treadmill
running).
Sunita Sharma: 6 months animal handling experience; has been to Laboratory Animal
Training.
Nick Smith: No experience with animals, but has been to Laboratory Animal Training;
training will be provided during experiment.
Jade Caldwell: No experience with animals, but has been to Laboratory Animal
Training; training will be provided during experiment.
Kyle Truska: No experience with animals and will attend Laboratory Animal Training;
training will be provided during experiment
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If additional personnel become involved in handling animals used in this protocol, it is the
responsibility of the principal investigator to notify the Animal Care Facility in writing
before they start.
Has the investigator/instructor and all personnel listed above received the appropriate
vaccinations (tetanus, rabies)?

Yes

No

Not Applicable

Will be done by the time the study is initiated.
Is it necessary for personnel listed on this protocol to be tested for TB?
Yes

No

If you have questions about the kind of vaccination or about TB, call the Animal Care
Facility at 678 2359.
All U of M personnel involved in this protocol must complete the animal care and use
training program before animals can be procured or before experiments/teaching or
demonstration. In submitting this protocol, I, as Principal Investigator/Instructor accept
the responsibility for compliance with this requirement.
In addition, the Principal Investigator/Instructor must be willing to provide appropriate
supervision for all persons working on this protocol. In the case of a class, the Instructor
must be responsible for training any students in classes involved prior to using animals.

II.

Project Description

A.

Summary (Enter a brief description below of your project, using lay terminology):
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Obesity has become an epidemic in the Western world, largely due to poor dietary
habits. Multiple dietary programs have been studied in recent years, showing promise
with regards to weight loss and improvement in multiple health related outcomes,
including glucose control, inflammation, and oxidative stress. More recently, a great
deal of attention has been placed on the microbiome and the influence of dietary intake
on this very important component of overall health. What is unknown is the degree of
improvement noted when following each of the popular dietary regimens as compared
to simple caloric restriction. That is, are certain protocols more beneficial than others
and if so, in regards to which specific outcome(s)? Much debate centers on these
questions and no study has sought to make direct comparisons between the wellinvestigated protocols.

In fact, most dietary protocols have simply been compared to a typical high fat
Western diet. Very few comparison studies have been conducted inclusive of the four
most common dietary approaches: Caloric Restriction (CR), Dietary Restriction (DR),
Time Restricted Feeding (TRF), and Alternate Day Fasting (ADF). The goal of the
present study is to directly compare the above four dietary plans to a Western Diet,
with regards to body mass/body fat, physical performance, insulin sensitivity,
inflammation, oxidative stress, and the microbiome. A diet of standard rodent chow
will be used as a control. Outcome measures will be determined after 8 weeks of
assignment to the dietary programs, with a total of 56 animals assigned to one of 7 diet
groups (n=8 per group).
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4 week old C57BL/6 male mice will be entrained under a 12h light: 12h dark schedule
for two weeks with standard rodent chow available ad libitum. During the entrainment
period, mice will begin the reverse light-dark schedule, with lights off between the
hours of 7am-7pm. This will be done so that the feeding time will be during the active
phase (“light off” phase) of the mice. Mice will be housed in Life Sciences in an area
that is currently used for studies of the circadian rhythm and therefore the light is wellregulated. After two weeks of entrainment, all but 8 mice will be switched to a Western
diet for four weeks, consisting of 45% fat with lard as the fat source. This additional
four week period of ad libitum feeding should allow for significant weight gain. Eight
mice will continue following a standard chow diet during this 4-week period and serve
as a low-fat control diet group. They will maintain this same diet throughout the entire
study period. Following the 4-week period, the mice fed the Western diet will be
divided into 6 additional groups: Western, CR, DR, TRF, ADF, and chow.

A MRI for the determination of body mass/fat and treadmill run to exhaustion will
occur at baseline (prior to starting the specific diet plan) and following eight weeks on
the specific diet assignment. Before and after the 4-week period of Western diet
feeding and at the end of the intervention period, a glucose tolerance test will be
performed. Mice will be fasted for 7 hours and glucose levels measured in 10 ul of
blood collected via the tail vein. Glucose will be administered intraperitoneally and
blood glucose measured every 30 minutes for 90 minutes from 10 ul of blood collected
from the tail vein. At the end of the dietary intervention, prior to sacrifice, blood will
be collected from the facial vein for the determination of lipids, glucose, insulin,
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oxidative stress markers, cytokines, immune cell populations, and other variables. All
mice will be sacrificed by CO2 inhalation. Tissues will be harvested immediately. This
form of euthanasia does not affect the outcome measures as determined by our
previous studies. Organs to be harvested are liver, spleen, intestine, lymph nodes,
adipose tissue, skeletal muscle, and heart.

B.

Describe IN DETAIL the procedures you will follow. Include accompanying

documentation and reference to previously published work in the box below. Provide a complete
bibliographic citation and describe any variations from the published technique. The
bibliography may be included in the box below or appended to this protocol.
Mice: 56, 4 week old C57BL/6 male mice will be purchased from Envigo or another
vendor. After arrival, mice will be co-housed (as done in reference 1) at the animal
facility on the University of Memphis campus.
After arrival at the University of Memphis, mice will be entrained under a 12h light:
12h dark schedule for two weeks with standard rodent chow available ad libitum.
During the entrainment period, the light-dark cycle will be reversed with lights off
between the hours of 7am-7pm. This will be done so that the feeding time will be
during the active phase (“light off” phase) of the mice. Mice will be housed in Life
Sciences in an area that is currently used for studies of the circadian rhythm and
therefore the light is well-regulated. After two weeks of entrainment, all but 8 mice
will be switched to a Western diet, consisting of 45% lard and 41% carbohydrate (20%
sucrose, 9% corn starch, and 12% Maltodextrin). This additional four week period of
ad libitum feeding should allow for significant weight gain. Following this period,
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mice will be divided into 6 additional groups and will consume their respective diets
for an additional 8 weeks.
Group 1 will have access to a standard rodent chow ad libitum, 24 hours per day.
Group 2 will have access to a purified, high-fiber, vegan-based diet ad libitum, 24
hours per day. We have used this same customized diet in past studies and it results in
normal weight/muscle mass gain, while minimizing fat accumulation. This will be the
DR arm of the trial.
Group 3 will have access to the Western diet ad libitum, 24 hours per day.
Group 4 will have ad libitum access to the Western diet for 6 hours at the beginning of
their active phase (7am-1pm). This will be the TRF arm of the trial. We have used this
exact feeding protocol in a recent investigation of mice. No negative health
consequences were observed using this protocol.
Group 5 will be on the alternate day fasting (ADF) protocol and have ad libitum access
to the Western diet every other day. That is, on day 1 they will have unrestricted access
to food during the entire 24 hour period. On day 2 they will receive no food. On day 3,
they will have unrestricted access to food, and so on. This same protocol has been
used in mice in several studies without incident. Please see references 2-10. It should
be noted that if the ADF protocol leads to significant weight loss beyond what would
be expected for mice following such a plan (≥20% body mass as compared to their
body mass at the start of the intervention period [after 4 weeks of following the ad
libitum Wester diet]) and/or mice show signs of stress or impaired health (e.g., scruffy
coat, hunched posture, excessively aggressive behavior), the attending veterinarian will
be notified and a rescue protocol will be set in place and will consist of the following:
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instead of receiving no food on the fasting days, mice will receive 20% of the daily
calories in the form of the Western diet during a one hour period at the mid-point of the
animals’ active phase (12-1pm).
It should be noted that animals in all groups will be monitored daily for signs of stress
and impaired health, with particular attention given to animals in the ADF group.
Monitoring body weight three times weekly should be more than adequate and should
not cause undue stress to the animals due to frequency of handling.
Group 6 will receive 80% of ad libitum intake of the Western diet as determined during
the prior 4 week period. This will be the CR arm of the trial. Multiple rodent studies
have reduced caloric intake by 20-40% without incident. See references 5 and 11-17.
Al mice will be monitored daily for sign of malnutrition and stress.
The diets will be purchased from Research Diets, which has experience in producing
the Western diet and purified vegan diets for rodent studies. The mice will remain on
their particular diets for eight weeks and then post-testing will begin. Mice will
continue on their diets until all testing is completed (~ end of week 9). Water will be
provided ad libitum throughout the study period. The amount of food consumed will be
measured daily and the weights of the mice will be taken three times per week at the
same time of day. There will be a total of 56 mice assigned in this study.
There will be two mice housed per cage. From our previous studies we know that
genetically similar mice eat basically a constant volume of food. We can therefore pairhouse the mice and determine an average amount of food consumed. Previous studies
have used a similar set up where 3-5 mice were co-housed (Hatori et al.). If there are
any signs of fighting or it appears that one the mice is consuming the majority of the
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food, those specific mice will be separated into individual cages. Food will be weighed
daily. Mice will be weighed 3 times per week at the same time of day. A glucose
tolerance test (GTT) will be performed at the beginning of the experiment (when mice
are put on their respective diets) and following 8 weeks after the start of the dietary
intervention. The final GTT will be performed 48h prior to euthanasia. For the glucose
tolerance test, mice will be fasted for a minimum of 7 hours and blood glucose levels
determined by blood from tail vein. Mice will be given a 1g glucose/kg body weight
intraperitoneally and blood (10ul) collected every 30 minutes for 90 minutes to
measure glucose levels. For blood collection, mice will be placed on a flat surface and
restraint by gently holding onto the tail without pulling. The tip of the tail will be
snipped – 1mm region. This part of the tail has little nerve innervation and does not
cause the animal any distress. By “milking” the tail, blood can be collected at multiple
time points without having to cut again. Isoflurane cannot be used as it increases blood
glucose levels independent of treatment. We have used this exact procedure in a recent
study.
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In addition to the GTT, prior to commencing the specific diet plans (after the initial 4 week
period on the Western diet), animals will undergo a MRI for determination of body mass/body
fat. Body composition will be determined using an EchoMRI™ 1100. The MRI is housed in
room 115 in Life Sciences, the same location that our mice are housed in. For scanning, animal
are placed with cylindrical tube holders and movement restricted to the bottom 7.5 cm as stated
in the instrument manual and the study by Jones et al. (Validation of quantitative resonance for
the determination of body composition of mice. Int. J Body Compos Res. 2009; 7(2):68-72). The
animals are scanned without anesthesia, sedation or restraint and are free to move within the
holder. The smallest possible holder is used to limit the movement of the mouse (without
constraining them) in order to reduce measurement errors induced by motion. Scanning time is
approximately 40 seconds. There is no prior training required for the animal. We have prior
experience using this system in mice.

Finally, animals will undergo a treadmill run test to exhaustion using a motorized
treadmill without incline. Specifically, mice will be acclimated to the treadmill prior to
testing. Run to fatigue test will be performed twice in the mice; once prior to starting
the 8 week intervention and at the end of the 8 week intervention. Animals will run
using a 5% grade at 20m/min for 30 min and 25m/min for the remaining time until they
reach exhaustion. A warm up phase will be provided for 15min (5min at 5m/min, 5min
at 10m/min, 5min at 15m/min). Fatigue will be defined as the time at which mice are
no longer able or willing to keep up with the speed of the treadmill despite gentle hand
prodding for a period of 30 seconds. Very mild electric shock will only be used if mice
do not respond well to gentle hand prodding. Our past and current work using running
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protocols demonstrates that mild shocking is preferable to obtain the best running
performance. The frequency and amplitude of shock will be as low as possible to
motivate the animals to remain on the treadmill belt, without causing unnecessary
distress. We have used small electric shock in prior studies and this is well-accepted in
rodent running studies. Equipment will be cleaned upon the completion of testing with
ethanol solution. All urine and feces will be cleaned off of the device and the
surrounding area.
After 8-9 weeks of dietary intervention, mice will be euthanized (CO2 inhalation) and
with cervical dislocation. Tissues will be harvested immediately. This form of
euthanasia does not affect the outcome measures as determined by our previous
studies. Organs to be harvested are liver, spleen, intestine, lymph nodes, adipose tissue,
skeletal muscle, and heart. Immediately prior to euthanasia, blood will be collected via
the facial vein to measure lipids, glucose, insulin, oxidative stress markers, cytokines,
immune cell populations, and other variables as needed. Cecum and intestinal contents
will be collected for microbiome analysis.
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C.

Rationale for Involving Animals and the Appropriateness of Species and Number Used.

Indicate (here) briefly the short and/or long-term benefits (to humans and/or other animals) of
this use of animals for research, teaching or demonstration. Provide rational for and the number
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of animals to be used. In addition, state briefly why living animals are required for this study,
rather than some alternative model.
The goal of this experiment is to study common feeding patterns in a controlled
environment over a moderate period of time to determine the cardio-metabolic health
effects of these dietary plans. Results will provide evidence for or against certain
models that can then be used by human subjects in an attempt to combat obesity and
related co-morbidities. We know from our prior work in rodents that the TRF and DR
models are favorable as compared to a WD. However, we are uncertain as to how CR
and ADF plans compare. Moreover, we are unaware of studies focused on comparing
these plans with regards to the microbiome or physical performance. These are
important areas of interest to scientists and humans who are focused on which dietary
plan may be “best.” As obesity is becoming more of a problem in the Western world,
determining which dietary approaches may be best to combat this disease is of great
importance.
The C57BL/6 diet induced obesity mouse model has been used previously to study the
effect of excess weight on various organ systems. As we are interested in the
interaction between the immune system, oxidative stress, physical performance, and
other organs, we cannot use isolated cell lines or model organisms such as yeast.
Additionally, many reagents have been developed for the use of mouse tissues,
especially antibodies that will be used to identify certain outcome measures. As we are
focusing on the effect of the different dietary programs on multiple organ systems, it is
only feasible in an animal study.
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There will be 8 mice per group for a total of 56 mice. This number is the norm for
similar studies of dietary-induced changes in our health-specific parameters. This
number should be sufficient to determine statistical significance for the tests planned
during this study.
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D.

Do the procedures described in B above, have the potential to inflict more
than momentary pain or distress (this does not include pain caused by
injections or other minor procedures)?

Yes

No

I have considered alternatives to procedures that might cause more than momentary or slight
pain/distress, and I have not found such alternatives. As such, I have used one or more of the
following methods and sources to search for such alternatives: (check below each method used)

Agricola Data Base

Medline Data Base

CAB Abstracts

TOXLINE

BIOSIS

Lab. Animal Sci. Journal

Lab. Animals Journal

Lab Animal

Animal Welfare Info Center

ATLA (Alternatives to Laboratory Animal Journal)

Quick Biblio. Series

Lab Animal Welfare Bibliography (QL55L27311988)

"Benchmarks"

"Alternatives to Animal Use in Research, Testing and Education"
Current Contents
CARL
Direct contact with colleagues (if selected, you MUST document this below)

List search words for the literature search:
Daniel Fast, dietary restriction, vegan fasting, fasting, time restricted feeding, intermittent
fasting, caloric restriction, alternate day fasting, chow, obesity, inflammation, oxidative stress,
microbiome, treadmill test, EchoMRI, insulin resistance, insulin sensitivity, fatty acids, body
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composition, glucose, insulin, blood sugar (words used in isolated and in combination in
PubMed and Google Scholar).

What is the length of time that the literature search covers?
1960-2017

III. Animal Use
A.

List all animal species to be used (example below).
Species Number1

Age2

Sex2

Weight2

Where Housed
(Bldg./Rm#)
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e.g. Hooded
45

2 months

male

250-350 gm

Psychology Bld./422I

56

4 weeks

Male

15-20 gm

Life Sciences/115

Wistar rats
C57Bl/6 mice

1Individuals

using ectotherms need to only approximate numbers.

2Individuals

using fish or other ectotherms need not answer this question.

Is any species threatened or endangered?

Yes
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No

B.

Source of animals
Commercial vendor (Source___ Envigo

Labs_____________________________________________)
Bred at The University of Memphis
Captured from wild. Identify method of capture:
Transferred from another study (IACUC Protocol Number
Donated (Source

)

Tennessee Wildlife Resources Agency
Is the supplier a USDA approved source?

Yes

No

Yes

No

If not, explain why:
Animals are already in residence at U of M

C.

Will surgery be conducted on animals?

If yes, complete this section:
Non Recovery Surgery

Recovery Surgery

Multiple Survival Surgery (if the latter is checked, complete section F)

Surgeon(s) (Name/Job/Title/Academic Rank)

D.

Location of Surgery (Bldg. & Room #)

Will Anesthetic(s), Analgesic(s), or
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Tranquilizing agents be administered?

Yes

No x

If yes, complete this section (example below).
Species & Sex

Agent

Dose Route Performed by
(Name/Title/Academic Rank)

e.g. male Hooded

sodium

50

i.p

Mr. Smith/Research

Wistar rats

pentobarbitol

mg/kg

.

Technician/B.S.

E.

Will euthanasia be carried out?

Yes

No

If yes, complete this section (example below).
Species & Sex Agent Dose Route Performed by (Name/Title/Academic Rank)
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e.g. male Hooded

sodium

150

i.p

Mr. Smith/Research

Wistar rats

pentobarbitol

mg/kg

.

Technician/B.S.

C57BL/6 mice

CO2

3L/min

In

Marie van der Merwe/

ha

Assistant Professor

lat

Matt Butawan/Research

io

Associate

n

Sunita Sharma/Master’s
Student (Will be trained by
Dr. Karyl Buddington)

If no, describe disposition of animal(s) at conclusion of this study in box below.

F.

Will special housing, conditioning, diets or other conditions
be required?

Yes
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No

If yes, please explain in box below.
Mice will be on high fat, chow, or purified diets. Some mice will have restricted access
to food, either 7am-1pm or every other day. Some mice will have access to only 80%
of their daily ad libitum intake.

G.

Will animals be removed from the U of M campus at any time?

Yes

If yes, please indicate to where and for how long in box below.

H.

If they are to be housed for more than 24 hours outside approved facilities at U of M,

provide a scientific justification in box below.
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No

IV. Toxic and Hazardous Substances
A.

Check off any of the following below that will be used in these experiments?
Infectious agents (Fill out a, b)
Radioisotopes (Fill out a, b, e)
Toxic chemicals or carcinogens (Fill out a, b)
Recombinant DNA (Fill out a)
Experimental drugs (Fill out a)
Malignant cells or hybridomas (Fill out a, c)
Adjuvants (Fill out a)
Controlled substances (Fill out a, d, e)

For each checked off category, answer the questions indicated below:
a.

Identify the substance(s) and completely describe their use, including how will be injected
or given to the animal(s):

b.

Describe all procedures necessary for personnel and animal safety including biohazardous
waste, carcass disposal and cage decontamination:

c.

If transplantable tumors or hybridoma cells are to be injected into the
animals, have the tissues/cells been tested for inadvertent contamination
by viruses or mycoplasma?

Yes

If yes, what was the result (indicate in box below).
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No

d.

In the box below, provide a complete list of these substances, and if their use is not
explicitly explained in the materials already provided, explain their use and role in the
research.

Provide DEA license # covering the use of these substances:
To whom (or what entity) is the license issued?
e.

Provide Radioisotope License Number:

To whom is the license issued?
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V.

Categories of Animal Experimentation Based Upon Level of Manipulation and Pain:

(check off each category that is applicable to this application)
A.

Animals will be involved in teaching, research, experiments or tests involving no
pain, distress, or use of pain-relieving drugs.

B.

Animals will be subject to mild stress only (e.g., food or water deprivation of less
than 24 hours for use in behavioral studies such as operant conditioning; physical
restraint for less than 30 minutes), and will not be subject to surgery, painful stimuli,
or any of the other conditions described below. Procedures described in this protocol
have the potential to inflict no more than momentary or slight pain or distress on the
animal(s)----that is, no pain in excess of that caused by injections or other minor
procedures such as blood sampling.

C.

Animals will have minor procedures performed, blood sampling, etc. while

anesthetized.
D.

Live animals will be humanely killed without any treatments, manipulations, etc. but
will be used to obtain tissue, cells, sera, etc.

E.

Live animals will have significant manipulations, surgery, etc. performed while
anesthetized. The animals will be humanely killed at experiment termination without
regaining consciousness.

F.

Live animals will receive a painful stimulus of short duration without anesthesia
(behavior experiments with flight or avoidance reactions--e.g., shock/reward)
resulting in a short-term traumatic response. Other examples in this category are,
blood sampling, injections of adjuvants, or drugs, etc.

Injection for glucose tolerance test; possible low grade shock while on treadmill.
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G.

Live animals will have significant manipulations performed, such as surgery, while
anesthetized and allowed to recover. Such procedures cause post-anesthetic
pain/discomfort resulting from the experiment protocol (e.g., chronic catheters.
surgical wounds, implants) which cause a minimum of pain and/or distress. Also
included are mild toxic drugs or chemicals, tumor implants (including hybridomas).
tethered animals, short-termed physically restrained animals (up to 1 hour),
mother/infant separations.

H.

Live animals will have significant manipulations or severe discomfort, etc. without
benefit of anesthesia, analgesics or tranquilizers. Examples to be included in this
category are: toxicity testing, radiation sickness, irritants, burns, trauma, biologic
toxins, virulence challenge, prolonged: restrictions of food or water intake, cold
exposure, physical restraint or drug addiction. All use of paralytic agents (curare-like
drugs) must be included in this category. Describe any abnormal environmental
conditions that may be imposed. Describe and justify the use of any physical restrain
devices employed longer then 1 hour.
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VI. Justifications for Category G Studies and Deviations from Standard Techniques
Describe in the box below any steps to be taken to monitor potential or overt pain and/or distress
during the course of this study and how such pain or distress will be alleviated. Be as detailed as
necessary to justify your procedure.

VII. Certifications
(By submitting this protocol, I am acknowledging that I comply with the certifications
included in Section VII.) (check one)
Animal Use for Research. I certify that the above statements are true and the protocol
stands as the original or is essentially the same as found in the grant application or
program/project. The IACUC will be notified of any changes in the proposed project, or
personnel, relative to this application, prior to proceeding with any animal experimentation.
I will not purchase animals nor proceed with animal experimentation until approval by the
IACUC is granted.
Animal Use for Teaching/Demonstration. I certify that the information in this application is
essentially the same as contained in the course outline and a copy of the laboratory
exercises using animals is on file in the IACUC office. The IACUC will be notified of any
changes in the proposed project, or personnel, relative to this application, prior to
proceeding with any animal experimentation. I will not proceed with animal
experimentation until approval by the IACUC is granted.
Estimate the cost of maintaining animals used in this protocol based on current per diem charge
at University of Memphis.
$7.20/day ($0.24/cage/day)
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Please specify cost per unit of time:
$756 (15 weeks)
Specify anticipated total costs for project duration:

As supervisor of this project it is required that you inform your department chair
concerning any animal per diem costs related to this project that are to be paid by the
department.

By submitting this protocol, the Principal Investigator/Course Director indicates that the
following have been considered:

1.

Alternatives to use of animals.

2.

Reduction of pain and stress in animals to the lowest level possible.

3.

The proper needs of the animals with respect to housing and care.

4.

The lowest number of animals used that will give the appropriate experimental results.

5.

Use of the most primitive species that will give the appropriate experimental results.

6.

Proper training of all personnel in the care and handling of the species used and in the
procedures called for in this protocol before beginning the experiment/teaching or
demonstration.

7.

That this protocol is not an unnecessary repeat of results already in the literature or in the
case of teaching/demonstrations, results that can be demonstrated using models or video
material.
Marie van der Merwe/Richard Bloomer
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Principal Investigator/Course Director (Type Name)

mvndrmrw@memphis.edu / rbloomer@memphis.edu
e-mail address

5/3/2017
Date
Federal Law requires that members of the IACUC be given adequate time to read and review
protocols including any changes or revisions in them.

Pre-review of protocols by the Attending Veterinarian is required before submission to the
IACUC. New protocols or modifications or renewals to protocols must be submitted to the
IACUC Chair by the 1st business day of the month to be considered for review during that
month. Incomplete protocols will be returned to the principal investigator.

E-mail the completed protocol to the IACUC Chair, Dr. Amy de Jongh Curry,
adejongh@memphis.edu

February, 2015
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